PRI-MED EAST

Transcription

PRI-MED EAST

PRI-MED EAST
September 11, 2014: Primary Care Updates
September 12–14, 2014: Annual Conference
Boston, MA
Boston Convention & Exhibition Center
Please Join Us for a Product Theater Lunch Presentation at
Pri-Med East 2014
HEPATIC ENCEPHALOPATHY:
A Clinical Dialogue on a Chronic
Complication of Cirrhosis
Friday, September 12, 2014
12:55 pm – 1:40 pm
Boston Convention and Exhibition Center
Presentation Theater #3 – Exhibit Hall Floor
Boston, Massachusetts
Steven Flamm, MD
Chief, Liver Transplantation
Northwestern Memorial Hospital
Professor of Medicine & Surgery
Northwestern University
Feinberg School of Medicine
Chicago, Illinois
This is a promotional event. CE/CME credit will not be available for this session.
In compliance with PhRMA guidelines, spouses or other guests are not permitted to attend companysponsored programs. This promotional educational activity is brought to you by Salix Pharmaceuticals
and is not certified for continuing medical education. The speakers are presenting on behalf of
Salix Pharmaceuticals and must present information in compliance with FDA requirements applicable
to Salix Pharmaceuticals.
If you are licensed in any state or other jurisdiction (eg, VT, Wash. DC, ME, MN) or are an employee or
contractor of any organization or governmental entity that limits or prohibits meals from pharmaceutical
companies, please identify yourself so that you (and we) are able to comply with such requirements.
Your name, the value, and the purpose of any educational item, meal, or other items of value you receive
may be reported as required by state or federal law. Once reported, this information may be publicly
accessible. Thank you for your cooperation.
Indication
XIFAXAN® (rifaximin) 550 mg tablets are indicated for reduction in risk of overt hepatic encephalopathy (HE) recurrence in patients ≥ 18 years of age.
Important Safety Information about XIFAXAN 550 mg
XIFAXAN® (rifaximin) 550 mg tablets are contraindicated in patients with a hypersensitivity to rifaximin, any of the rifamycin antimicrobial agents, or any of the components in
XIFAXAN. Hypersensitivity reactions have included exfoliative dermatitis, angioneurotic edema, and anaphylaxis.
Clostridium difficile-associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including XIFAXAN, and may range in severity from mild diarrhea
to fatal colitis. Treatment with antibacterial agents alters the normal flora of the colon which may lead to overgrowth of C. difficile. If CDAD is suspected or confirmed, ongoing
antibiotic use not directed against C. difficile may need to be discontinued.
There is increased systemic exposure in patients with more severe hepatic dysfunction. The clinical trials were limited to patients with MELD scores < 25. Therefore, caution
should be exercised when administering XIFAXAN to patients with severe hepatic impairment (Child-Pugh C).
Concomitant administration of drugs that are P-glycoprotein (P-gp) inhibitors with XIFAXAN can substantially increase the systemic exposure to XIFAXAN. Caution should be
exercised when concomitant use of XIFAXAN and a P-gp inhibitor such as cyclosporine is needed. In patients with hepatic impairment, a potential additive effect of reduced
metabolism and concomitant P-gp inhibitors may further increase the systemic exposure to XIFAXAN.
Based on animal data, XIFAXAN may cause fetal harm. Discontinue in nursing mothers after taking into account the importance of the drug to the mother.
The most common adverse reactions occurring in ≥ 10% of patients and at a higher incidence than placebo in the clinical study were edema
peripheral (15%), nausea (14%), dizziness (13%), fatigue (12%), and ascites (11%).
Presented by
Xifaxan 550 mg is licensed by Alfa Wassermann S.p.A. to Salix Pharmaceuticals, Inc.
Please see complete Prescribing Information at XIFAXAN550.com.
© 2014 Salix Pharmaceuticals, Inc.
07/14
XIFH10-0114
General Conference Information Primary Care Updates Sessions Annual Conference Session Schedule
Featured CME Sessions
Continuing Medical Education Information
Primary Care Updates Session Information
Annual Conference Session Information
Speaking Faculty for Primary Care Updates
and Annual Conference
Financial Disclosures
Exhibitors Maps of the Convention Center 4
6
8-11
12-13
14-16
18-19
19-22
24-25
26-27
28-31
32-35
General Conference Information
Table of Contents
3
Ticket Booth*: North Lobby, Level 1
Friday, September 12
Saturday, September 13
Sunday, September 14
6:45am–4:30pm
6:45am–4:30pm
6:45am–12 noon
*Ticket booth will remain open each day until all available tickets have been distributed.
Exhibit Hall: Ground Level
8:30am–2:30pm
8:30am–2:30pm
8:30am–2pm
•
6:45am–3:30pm
6:45am–4:30pm
6:45am–4:30pm
6:45am–12 noon
BOSTON, MA
Thursday, September 11
PRI-MED EAST ANNUAL CONFERENCE
Registration: North Lobby, Level 1
SEPTEMBER 2014
Hours of Operation
Annual Conference Syllabi
The outlines of the lectures presented in the Pri-Med East program
are available online at www.pri-med.com/11EST14A/syllabus for
eight weeks following the conference.
Badge and Attendance Scancard
As a Pri-Med registrant, you will receive a badge that will have a
QR code programmed with just your badge number. You need to
scan your QR code at the appropriate stations to obtain CME credit
or nursing contact hours. Scanning your badge at an exhibit booth
or non-CME activity means that you are giving the sponsor the
option to use your contact information for future correspondence.
BOSTON, MA
•
SEPTEMBER 2014
4
Badge Correction/Lost Badges
If you have lost your badge or the badge has been prepared
incorrectly, please go to the Pri-Med Registration Counters located
on Level 1 in the North Lobby, where a new badge will be prepared.
Wi-Fi Access
The Boston Convention & Exhibition Center offers complimentary
Wi-Fi throughout the center. Here’s how to connect:
Three easy steps
1. Go to “settings” on your mobile device.
2. Select the Wi-Fi option.
3. Click “BCEC Wireless Network.”
Notice: Physician Payment Sunshine Act
In adherence to federal regulations, physicians are advised
that your information, including your name and the value and
purpose of any meal, beverage, educational item or other items
of value you receive from a pharmaceutical or medical device
manufacturer or group purchasing organization may be reported
by these organizations for public disclosure.
Lost and Found
If you have questions or are unsure whether an item you wish
to accept is reportable, please ask a company representative
at the appropriate booth for more information.
Management Office
For the full Physician Payment Sunshine Act policy, visit
www.CMS.gov under Regulations and Guidance, National
Physician Payment Transparency Program (Open Payments).
Any Lost and Found items can be delivered/picked up at the
Information Booth located on Level 1 in the North Lobby.
The Management Office is located in Room 151A on Level 1.
You are invited to visit us in this office any time you feel that
we can be of assistance to you.
Parking
The Boston Convention & Exhibition Center (BCEC) offers two
parking options: valet and self-parking.
NEW PROCESS for Evaluation and Claiming
Education Credit
Our credit award procedure has changed. Please follow these
instructions for evaluating and claiming continuing education
credit for sessions you attend at this Pri-Med meeting:
• Valet parking is available by turning into the BCEC’s east side
entrance off Summer Street (Westin Hotel side); valets are
immediately on your right. Valet parking is $25 all day.
1. Be sure to scan your badge once each day near
the session rooms to activate your identification
for credit award.
• For self-parking, continue beyond the valet area. At the end
of the building, turn right and go down the ramp. At the
bottom, turn left and you will see the entrance to the south
parking lot. Self-parking is $12 all day. Complimentary shuttle
buses run continuously between the south parking lot and
the west side building entrance every 5–10 minutes.
2. Go to www.pri-med.com/11EST14A/eval to access
the online credit system, using any computer or
Internet-interactive device to complete the evaluation
and credit request process. A limited number of
computers are available onsite, and Pri-Med staff can
assist you with the process if you have questions:
Questions?
We’re here to help! Please visit the Information Booth located on
Level 1 in the North Lobby or the Pri-Med Booth, #1529, or find any
Pri-Med staff member for assistance.
Spouse/Children Attendance
Spouses and/or significant others of registered professional
attendees may attend the Pri-Med Exhibit Hall when accompanied
by a professional attendee. These individuals should go to the
Registration area and register for a guest badge for $35. We regret
that because of space limitations we cannot accommodate guest
registrants in the conference sessions.
So that we can provide all Pri-Med attendees with optimal learning
environments, children under the age of 16 years are not permitted
in the Exhibit Hall.
• Enter your badge number and email address for
identification.
• Evaluate the overall activity by answering the activity
evaluation questions.
• On the session screen, identify the sessions that you
have attended.
• Evaluate each session by clicking on each session link
and answering the evaluation questions.
• Confirm total credit award for each session and attest
to correct total.
• Designate the type of credit you seek.
3. Receive your credit. Your certificate of credit will be
posted to your CME Tracker on Pri-Med.com.
SEE YOU NEXT YEAR!
Register for the 2015 Annual Conference (September 17–20, 2015) at the Pri-Med Booth, #1529,
or at the Registration Desk. Registration is available at the lowest cost of $40.
REGISTER
REGISTER FOR NEX T YEAR’S
ANNUAL CONFERENCE FOR JUST $40.
PRI-MED EAST
SEPTEMBER 17-20, 2015
BOSTON, MA
Follow the orange footsteps in the
Exhibit Hall to the Pri-Med Booth #1529
or visit Registration in the North Lobby, Level 1.
Primary Care Updates
Thursday, September 11, 2014
Track 1- Grand Ballroom, Level 3
7:45–9am
Managing Shift Work Disorder in Primary Care: Overcoming Barriers to Improve
Patient Outcomes
Charles A. Czeisler, MD, PhD, FRCP
Karl Doghramji, MD
Paul P. Doghramji, MD, FAAFP
9–9:15am
Networking Break
Primary Care Updates
9:15–10:30am
Applying Stroke and Bleeding Risk Assessment in Atrial Fibrillation to Optimize
Anticoagulation Therapy
Bruce Stambler, MD
BOSTON, MA
•
SEPTEMBER 2014
6
10:30–11:45am
Improving Outcomes in Type 2 Diabetes: Integrating GLP-1 Receptor Agonists
Into Multimodal Treatment Regimens
Vivian A. Fonseca, MD
Lawrence Blonde, MD, FACP, FACE
Mark W. Stolar, MD
7:45–9:15am
Improving Outcomes for Acute Coronary Syndrome Patients: Best Practices for
Primary Care Clinicians
Jessica Mega, MD, MPH
Benjamin Scirica, MD, MPH
9:15–9:30am
Networking Break
9:30–10:30am
Gout: Optimizing Disease Management 2014
Michael Pillinger, MD
Mark C. Fisher, MD, MPH
10:30–11:45am
The Evaluation and Treatment of Benign Prostatic Hyperplasia and Lower
Urinary Tract Symptoms in the Primary Care Setting
Martin Miner, MD
Matt T. Rosenberg, MD
11:45am–12:30pm
11:45am–12:30pm
Lunch Break
Lunch Break
12:30–1:45pm
Caring for Patients with Chronic Pain: Responsible Opioid Prescribing to Achieve
Individualized Functional Goals
Michael J. Brennan, MD
David M. Simpson, MD, FAAN
Bill H. McCarberg, MD
12:30–2pm
Against All Odds: Improving Insulin Use in T2DM through Individualized Clinical
Decision Making
Richard E. Pratley, MD
Frank Lavernia, MD
Paul S. Jellinger, MD, MACE
1:45–2pm
Networking Break
Networking Break
2–3:30pm
Current Perspectives and Emerging Approaches in Lipid Management
Eliot A. Brinton, MD
JoAnne M. Foody, MD, FACC, FAHA
Current Approaches to Infectious Diseases in Primary Care
Kalpana Gupta, MD, MPH
2–2:15pm
2:15–3:30pm
Session times are preliminary. Sessions and schedule subject to change. These activities are provided by pmiCME.
To date, the following organizations have provided educational grants in support of Primary Care Updates Track 1: AstraZeneca; Boehringer Ingelheim Pharmaceuticals, Inc.;
Daiichi Sankyo, Inc.; Teva CNS; Teva CNS and Endo Pharmaceuticals.
To date, the following organizations have provided educational grants in support of Primary Care Updates Track 2: AstraZeneca; Lilly. For further information concerning Lilly grant
funding, visit www.lillygrantoffice.com; Novo Nordisk Inc.; Takeda Pharmaceuticals International, Inc., U.S. Region.
For full information on accreditation and credit designation, please see the Continuing Medical Information pages in this guidebook.
Industry Sponsored CME Sessions
Track 2- Room 210, Level 2
KNOWLEDGE ZONE
The Knowledge Zone is the single best source for small group presentations and
opportunities for 1:1 discussions with industry experts. Topics focus on health
and wellness through the eyes of preventive care, diagnosis, treatment decisions,
and patient adherence.
Located in the Exhibit Hall in Booth #1912.
DATE
TIME
TITLE
PRESENTED BY
9:00 - 9:15 am
Non-invasive peripheral small
nerve fiber testing within the
Physician Office
Impeto-Medical
9:20 - 9:35 am
NEJM Knowledge+: The Adaptive
Learning Advantage for Medical
Professionals
NEJM Group
12:15 - 12:30 pm
Adding Flavor to Heart Health with
Lean Beef
The Beef Checkoff
Saturday, September 13, 2014
9:20 - 9:35 am
NEJM Knowledge+: A Novel
NEJM Group
Approach to Board Review and MOC
12:35 - 12:50 pm
High Sensitivity Cardiac Troponin I:
Out of the ER and Into Chronic
Disease Management
Singulex, Inc.
Pri-Med East Sessions
Annual Conference curriculum developed in collaboration with the American College of Physicians.
Hands-on workshops on the latest ultrasound technologies developed in collaboration with the
University of South Carolina School of Medicine Ultrasound Institute.
7:45–8:45am
KEYNOTE: The Future of Medicine
Daniel Kraft, MD
Hall B, Ground Level
8:45–9:45am
NETWORKING BREAK AND ADDITIONAL OPPORTUNITIES
8:55–9:40am
Bipolar Depression: Presentation, Diagnosis, and Treatment
Brought to you by Sunovion Pharmaceuticals Inc.
Session Schedules
9:45–10:45am
10:45–11:45am
Exhibit Hall Floor - Theater 2
Targeting Better Cardiac Outcomes for High-Risk Patients
Daniel Soffer, MD, FNLA
Ultrasound for the PCP
Richard Hoppmann, MD, FACP
Grand Ballroom, Level 3
Understanding Dyslipidemia Testing and Screening: Importance of
Lipoprotein Particle Analysis
Matthew Sorrentino, MD, FACC, FASH
Introduction to Ultrasound and Case Presentations
Victor Rao, MBBS, DMRD , RDMS
Michael Wagner, MD
Keith Barron, MD
11:45am–1:45pm
8
11:50am–12:35pm
Improving Glycemic Control:
A New SGLT2 Inhibitor for
the Treatment of Adults
with Type 2 Diabetes
Brought to you by Boehringer
Ingelheim Pharmaceuticals Inc.
Pneumococcal Pneumonia and
Invasive Disease in Adults: Help
Protect Your Patients Aged 50+
Brought to you by Pfizer, Inc.
Discussion of a Treatment Option
for Major Depressive Disorder
Brought to you by Takeda
Pharmaceuticals U.S.A., Inc. & Lundbeck
GENETIC COPD: Rule out Alpha-1
in COPD Patients
Brought to you by Grifols
Room 153 - Theater 4
12 noon—1:30pm
Symposia Lunch: Engaging Your Patient in Obesity Management: Techniques, Tactics, and Tools for Customized Disease Treatment
Brought to you by an independent educational grant from Novo Nordisk Inc.
SEPTEMBER 2014
Location: Room 210, Level 2
12:55–1:40pm
LIVALO: Emerging Clinical
Considerations and Key
Attributes
Brought to you by Kowa
Pharmaceuticals America, Inc.
PCPs and IBD: A Critical
Connection
Brought to you by AbbVie
Hepatic Encephalopathy: A Clinical Dialogue on a Chronic
Complication of Cirrhosis
Brought to you by Salix Pharmaceuticals, Ltd.
BOSTON, MA
•
Session times are preliminary. Sessions and schedule
subject to change. These activities are provided by pmiCME.
For full information on accreditation and credit designation,
please see the Continuing Medical Information pages in this guidebook.
Curriculum developed in collaboration with the ACP
Industry Sponsored Non-CME Activity
CME Educational Symposia
Curriculum developed in collaboration with the
University of South Carolina School of Medicine Ultrasound Institute
Distribution of tickets for ticketed events will happen at the
Ticket Booth, located in the North Lobby on Level 1,
beginning at 6:45 each morning, as follows:
Friday, September 12: Ticket pick-up is available for Friday
ticketed events. Limit 2 tickets per person.
Saturday, September 13: Ticket pick-up is available for
Saturday and Sunday ticketed events. Limit 4 tickets per person.
To download Syllabus, please visit: www.pri-med.com/11EST14A/syllabus
Hands-on workshops on the latest ultrasound technologies developed in collaboration with the
University of South Carolina School of Medicine Ultrasound Institute.
1:45–3:15pm
*Insulin Therapy in Patients with Type 2 Diabetes: Current and
Emerging Basal Insulins
Andrew Ahmann, MD, MS
James R. Gavin III, MD, PhD
1:45–2:30pm
Evaluation Is Essential for Safe
and Effective Pain Management
Using ER/LA Opioids
2:30–3:15pm
Best Practices for How to Start
Therapy with ER/LA Opioids,
How to Stop and What to Do in
Between
1:45–6pm
3:15–3:45pm
Engaging e-Patients: How e-Messaging, Personal Health Records,
and Patient Activation Can Transform Your Practice
Daniel Sands, MD, MPH
3:45–4pm
NETWORKING BREAK
3:15–3:45pm
Evidence-Based Tools for
Screening for Patients at Risk
and Monitoring for Adherence to
Prescribed ER/LA Opioids
4–5pm
Test Your Skills in Difficult Cases: Atrial Fibrillation
Kent Nilsson, MD, FACC
4–4:30pm
Talk to Me: Proven Methods to
Counsel Your Patients on ER/LA
Opioids and Achieve Positive
Outcomes
5–6pm
Tips for Managing Behavioral Issues in Elderly Patients
with Dementia
Katherine Galluzzi, DO, FACOFP, CMD
Ultrasound Workshops
(currently at capacity,
pre-registration was required.)
1–5pm
Hands-on diagnostic workshops
developed with the University
of South Carolina School of
Medicine Ultrasound Institute.
(was offered at an additional cost)
Ultrasound Workshops will include
six rotating modules on:
1) Neck (thyroid, and ultrasound principles)
2) Basic ECHO
3) Aorta
4) Inferior Vena Cava
5) Abdomen (gallbladder and liver)
6) Knee (includes guided procedures)
Room 205A, Level 2
4:30–5pm
Everything You Always Wanted
to Know about ER/LA Opioids as
a Drug Class
Session Schedules
SAFE Opioid Prescribing**
Charles Argoff, MD; Michael
Brennan, MD, FACP, FASAM;
Jeffrey Gudin, MD
9
5–5:30pm
Getting the Most Clinical Insights
from Specific ER/LA Product
Information Sources
5:30–6pm
Medical Brain Game
SEPTEMBER 2014
6:15–8:30pm
Workshop: A Hands-On Approach to COPD Treatment
Christopher Cooper, MD
Emily Wan, MD
Room 210, Level 2
Brought to you by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
SAFE Opioid Prescribing | This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic
REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is fully
compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food and Drug Administration (FDA).
**pmiCME designates the SAFE Opioid Prescribing session for 4.0 credits of Pain Management. Please check your individual state
licensing board requirements before claiming Pain Management credit.
For full information on accreditation and credit designation, please see the Continuing Medical Information pages in this guidebook.
SAFE Opioid Prescribing
Industry-Sponsored CME Session
CME Educational Symposia
Curriculum developed in collaboration with the
University of South Carolina School of Medicine Ultrasound Institute
Distribution of tickets for ticketed
events will happen at the Ticket
Booth, located in the North Lobby
on Level 1, beginning at 6:45 each
morning, as follows:
Friday, September 12: Ticket
pick-up is available for Friday
ticketed events. Limit 2 tickets
per person.
Saturday, September 13: Ticket
pick-up is available for Saturday
and Sunday ticketed events.
Limit 4 tickets per person.
Session times are preliminary. Sessions and schedule subject to change. These activities are provided by pmiCME.
BOSTON, MA
•
*To date, Pri-Med East has been supported by educational grants from Sanofi US Diabetes and AstraZeneca.
7:45–8:45am
KEYNOTE: Laughter Is the Best Medicine
Brad Nieder, MD, CSP
Location: Hall B, Ground Level
8:45–9:45am
8:55–9:40am
Emerging Trends in Alzheimer’s Disease Management:
Namenda® XR—a Treatment Option for Moderate to
Severe Patients
Brought to you by Forest Pharmaceuticals, Inc.
9:45–10:45am
Obstructive Sleep Apnea: Interventions That Will Help Your
Patients Sleep Better
Jonathan Lown, MD
Session Schedules
10:45–11:45am
VTE Prevention: Avoiding the Avoidable in Medical and HighRisk Patients
Gregory Piazza, MD
11:45am–1:45pm
12-1:30pm
Infectious Diseases Update in Primary Care
Location: Grand Ballroom, Level 3
Fighting a Growing Epidemic: A Viral Hepatitis Update
Nancy Reau, MD
11:50am–12:35pm
Improving Glycemic Control through DPP‐4 Inhibition:
Treatment Considerations for Adult Patients with Type 2 Diabetes
Brought to you by Boehringer Ingelheim Pharmaceuticals Inc. and Lilly USA
Diagnosis and Management
of Overactive Bladder
Brought to you by Astellas Pharma
Understanding the Data—Exocrine
Pancreatic Insufficiency
Advancing Paradigm Changes in Type 2 Diabetes Management
Brought to you by Janssen Pharmaceuticals, Inc.
Evaluating and Determining Patients
for Cardiac Radionuclide Imaging
Brought to you by Astellas Pharma
Rethink HCV
Brought to you by
Gilead Sciences
1:45–3:45pm
Live Demonstration Orthopedic Exam:
See It, Do It
Christopher Smith, MD, FACP
1:45—3pm
*Addressing Renal-Mediated Glucose Homeostasis: Diabetes and the Kidney
William M. Sullivan, MD
3—3:45pm
Medical Brain Game 2014: PCP Edition
M. Susan Burke, MD, FACP; Katherine Galluzzi, DO, FACOFP, CMD
3:45–4pm
4–5pm
Lipid Management: A Primary Care Perspective
Alan Brown, MD, FACC, FNLA, FAHA
The Problem Pests: Ticks, Mites, Bed Bugs and Lice
Stephen Gluckman, MD, FACP
New Insights into Reducing CV Risk in Patients with Type 2
Diabetes
JoAnne Foody, MD, FACC, FAHA
Critical Caveats for Common Medications
Douglas Paauw, MD
•
SEPTEMBER 2014
Room 205A
12:55–1:40pm
BOSTON, MA
Men’s Health Care Spotlight:
The Management and Treatment
of Erectile Dysfunction
Brought to you by Auxilium
Pharmaceuticals, Inc.
Unshackle Me: The Power of Google Glass to Liberate
Panelists include: Karandeep Singh, MD; Jennifer Joe, MD; Tristan Gorrindo, MD; Stephanie Shine, RN; Don Schwartz, and Carlos Rodarte.
Brought to you by: VectorSpect Marketing, MedTech Boston and Medstro.com.
10
5–6pm
Understanding Dupuytren’s Contracture:
Disease Awareness for the General
Practitioner
Brought to you by
Auxilium Pharmaceuticals, Inc.
*To date, Pri-Med East has been supported by educational grants from
Sanofi US Diabetes and AstraZeneca.
For full information on accreditation and credit designation,
please see the Continuing Medical Information pages in this guidebook.
Industry-Sponsored CME Session
Sunday, September 14, 2014
7:45–8:45am
KEYNOTE: Obesity in America from the Dietary Counselor and Lifestyle Coach from The Biggest Loser
Michael Dansinger, MD
8:45–9:45am
8:55–9:40am
Supporting Nurse Practitioners and Physician Assistants in Diabetes Care: Targeting the Kidney in Type 2 Diabetes
Brought to you by Janssen Pharmaceuticals, Inc.
Women’s Health Update: Clinical Pearls for Primary Care
Kelly Spratt, DO, FACC, FACP
10:45–11:45am
11:45am–1:45pm
11:50am–12:35pm
12:55–1:40pm
Lung Sounds: A Primer on Pulmonary
Auscultation
Salvatore Mangione, MD
Improve Patient Outcomes with Effective Diagnosis and Treatment of Underlying
Psychiatric Disorders
Rosalind Kaplan, MD, FACP
Understanding Patient-Specific Factors in
Stroke Prevention in Atrial Fibrillation (SPAF)
Brought to you by Daiichi Sankyo, Inc.
Addressing Chronic Weight Management
with Targeted Pharmacotherapy
Brought to you by Eisai, Inc.
Understanding Triglycerides
Brought to you by AstraZeneca
Pharmaceuticals LP
Optimizing Inhaler Technique in
Patients With Respiratory Diseases
Brought to you by Teva Pharmaceutical Industries Ltd.
Facts on Male Hypogonadism
Session Schedules
9:45–10:45am
In Search of Joy in Practice: Innovations in
Patient-Centered Care
Christine Sinsky, MD; Thomas Sinsky, MD
11
1:45–2:45pm
Hot off the Press and into Your Practice 2014
Marie Brown, MD, FACP
*About My Error
David Ring, MD, PhD
Optimizing the Management of Patients with Chronic Kidney Disease
Ali Assefi, MD
*pmiCME designates the session About My Error for 1.0 credit of Patient Safety, Risk
Reduction or Risk Management. Please check your individual state licensing board
requirements before claiming Patient Safety, Risk Reduction or Risk Management credit.
For full information on accreditation and credit designation, please see the Continuing
Medical Information pages in this guidebook.
BOSTON, MA
•
2:45–3:45pm
Practical Approaches to the “Dizzy” Patient
Aashish Didwania, MD, FACP
SEPTEMBER 2014
Keynote Addresses
FRIDAY, SEPTEMBER 12
7: 45–8:45am | KEYNOTE ADDRESS
The Future of Medicine
Daniel Kraft, MD
Daniel Kraft, MD, is a Stanford- and Harvard-trained physician-scientist, inventor, entrepreneur
and innovator. With over 20 years of experience in clinical practice, biomedical research, and
healthcare innovation, Kraft has chaired the Medicine Track for Singularity University since SU’s
inception, and he founded and is Executive Director of FutureMed (now called Exponential
Medicine), a program that explores convergent, rapidly developing technologies and their
potential in biomedicine and healthcare.
SATURDAY, SEPTEMBER 13
7:45–8:45am | KEYNOTE ADDRESS
12
Laughter Is the Best Medicine
Brad Nieder, MD, is a funny doctor, keynote speaker, and clean comedian who blends healthcare
humor with wellness advice and an uplifting message. Audiences love his “Laughter Is the
Best Medicine” program, finding it entertaining and inspiring (and informative, too), as Dr. Brad
explains–without being boring–how laughter really is good medicine ... for managing pain,
enhancing immune system function, reducing stress and more).
SUNDAY, SEPTEMBER 14
7:45–8:45am |
KEYNOTE ADDRESS
Obesity in America from
the Dietary Counselor
and Lifestyle Coach from
The Biggest Loser
BOSTON, MA
•
SEPTEMBER 2014
Michael Dansinger, MD, is the
nutrition doctor for NBC’s hit prime-time series The
Biggest Loser, Diabetes Doctor for WebMD, and
Director of the Diabetes Reversal Program at Tufts
Medical Center in Boston. He will share his insights
and opinions about the global obesity epidemic,
the USDA food pyramid, popular weight loss diets,
reality weight loss shows, losing 100 pounds in 100
days, obesity surgery, reversing type 2 diabetes,
how to feed your children, and what to do about
“decadent mouthwatering quadruple-layer
chocolate molten-lava fudge cake.”
The Original Non-toxic
has a New Look!
Licefreee!® has been changing the way parents
treat head lice since 1999 by offering an effective,
non-toxic solution that is pleasant and easy to use.
Instead of using toxic chemical pesticides,
Licefreee! uses sodium chloride to kill lice AND nits.
JUST SPRAY & GO!
Licefreee Spray® Instant
Head Lice Treatment kills
lice and nits on contact.
Visit booth 1519 to get
your sample.
(while supplies last)
NEW LOOK!
PrimedEast ad_0614.indd 1
800-482-4464
teclabs.com
6/6/14 4:55 PM
Strategies. Assessment. Fundamentals. Education.
Friday, September 12, 1:45–6pm
Approximately 100 million adults, representing 33% of the
population, suffer daily with chronic pain.
There are many approaches to managing this diagnosis,
and ER/LA opioids are among the most commonly used
medications. While they are effective pain relievers, there are
a number of risks that must be taken into consideration when
prescribing these opioids.
Pri-Med, in collaboration with American College of Physicians,
has received commercial support for the SAFE Opioid
Prescribing training by an independent educational grant from
the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the
member companies. This activity is fully-compliant with the
ER/LA Opioid Analgesics REMS education requirements issued
by the U.S. Food & Drug Administration (FDA).
Charles Argoff, MD, FABPM
Steven P. Stanos, DO, FABPM
Professor of Neurology, Albany Medical Center
Director, Comprehensive Pain Program, Albany Medical Center
Albany, New York
*Dr. Argoff receives advisor/consultant honoraria from Endo, Collegium
Pharmaceutical, Depomed, Lilly, Ameritox, QRX Pharma, Pfizer, Daiichi-Sankyo, Teva
Pharmaceutical expert investigator honoraria from Endo, Alllergan, Janssen, Miller
Labs, Lilly and receives grants from Endo/Lilly and Forest Laboratories.
Medical Director, Center for Pain Management, Rehabilitation Institute of Chicago
Assistant Professor, Department of Physical Medicine and Rehabilitation
Assistant Program Director, Multidisciplinary Pain Fellowship, Feinberg School of
Medicine Northwestern University
Chicago, Illinois
*Dr. Stanos receives advisory board/consultant honorarium from
Endo Pharmaceuticals, Pfizer, MyMatrixx and GlaxoSmith Kline.
Medical Director, Pain Center of Fairfield, Fairfield, Connecticut
Associate Director, Chronic Pain and Addiction, Silver Hill Hospital
New Canaan, Connecticut
*Dr. Brennan receives speaker bureau honorarium from Endo Pharmaceticals, Purdue
and consultant honorarium from Covidien and Teva Pharmaceutical.
Jeffrey Gudin, MD
Director, Pain and Palliative Care
Englewood Hospital and Medical Center
Englewood, New Jersey
*Dr. Gudin receives speaker bureau honorarium from Endo Pharmaceticals, Covidien,
Nektar, Pfizer, Purdue and consultant honorarium from Alere, and Shionogi.
The following clinicians are the Content Developers and Faculty for the SAFE Opioid Prescribing training.
13
Bill H. McCarberg, MD, FABPM
Attend all 6 sessions and join a Meet and Greet with the faculty, featured book signing
"Defeat Chronic Pain Now!" with co-author Dr. Charles Argoff
BOSTON, MA
•
SEPTEMBER 2014
Founder, Chronic Pain Program, Kaiser Permanente
San Diego, California
*Dr. McCarberg receives advisor honorarium from Iroko, NeurogesX, Pfizer, Salix,
Sucampo, Teva and Zogenix.
Groundbreaking Strategies for Eliminating the Pain of Arthritis, Back and Neck Conditions, Migraines, Diabetic Neuropathy, and Chronic Illness.
By Charles Argoff and Bradley S. Galer. Published December 1, 2010, by Fair Winds Press.
*Books are on a first-come, first-served basis.
www.pri-med.com/11WST14A/syllabus
Defeat Chronic Pain Now!
Primary Care Updates CME Information
14
Primary Care Updates – September 11, 2014
Physician Assistants:
Target Audience
This program is intended for clinicians in primary care, family
medicine, pediatrics, and internal medicine.
AAPA accepts certificates of participation for educational
activities certified for AMA PRA Category 1 credit™ from
organizations accredited by ACCME. Physician assistants may
receive Certificate of Attendance for a maximum of 6.5 hours
of AMA PRA Category 1 credit™ for completing this program.
Learning Objectives for Primary Care Updates Sessions*
• Assess new information on new guidelines, practices,
therapies and/or tools that you can use to diagnose, treat
and/or manage health problems you see in your practice.
• Evaluate applicability of the new information to your
own practice and specific opportunities to improve your
patients’ quality of care and health outcomes.
• Demonstrate your ability to adopt the new information
by interactive participation in case-based learning and
discussing common challenges and ways to overcome
barriers to implementation.
*Individual sessions will post topic-specific learning objectives.
Faculty and Disclosures
Please see page 26 for financial disclosure information for faculty
and other content contributors.
Certificate Instructions – NEW
Please see the information noted to the right under
NEW PROCESS for Evaluation and Claiming Education
Credit for detailed instructions on completing online
evaluation and credit request.
Physicians:
ACCME Accreditation Statement
BOSTON, MA
•
SEPTEMBER 2014
pmiCME is accredited by the Accreditation Council for
Continuing Medical Education to provide continuing medical
education for physicians.
AMA PRA Designation Statement
pmiCME designates this live activity for a maximum of
6.5 AMA PRA Category 1 credits™. Physicians should claim
only the credit commensurate with the extent of their
participation in the activity.
Family Practice Physicians:
This live activity, Primary Care Updates Track 1 from 09/11/14
to 09/11/14, has been reviewed and is acceptable for up to
6.5 prescribed credit(s) by the American Academy of Family
Physicians (AAFP).
This live activity, Primary Care Updates Track 2 from 09/11/14
6.5 prescribed credit(s) by the American Academy of Family
Physicians (AAFP).
Nurse Practitioners:
pmiCME is approved as a provider of nurse practitioner
continuing education by the American Association of Nurse
Practitioners. AANP provider 040308. This program has been
approved for 6.5 contact hours of continuing education
(which includes 3.25 hours of pharmacology).
Education Credit
Our credit award procedure has changed. Please follow
these instructions for evaluating and claiming continuing
education credit for sessions you attend at this Pri-Med
meeting:
1. Scan your badge. Be sure to scan your badge once each
day near the session rooms to activate your identification
for credit award.
2. Go to www.pri-med.com/11EST14A/eval to access
the online credit system, using any computer or Internetinteractive device to complete the evaluation and credit
request process. A limited number of computers are
available onsite, and Pri-Med staff can assist you with the
process if you have questions:
• Enter your badge number and email address for
identification.
• Evaluate the overall activity by answering the activity
evaluation questions.
• On the session screen, identify the sessions that you
have attended.
• Evaluate each session by clicking on each session link
and answering the evaluation questions.
• Confirm total credit award for each session and attest
to correct total.
• Designate the type of credit you seek.
3. Receive your credit. Your certificate of credit
will be posted to your CME Tracker on Pri-Med.com.
• Draw on the experience of expert faculty and compare
your patient care practices with those of your colleagues to
help you improve your patients’ quality of life, encourage
the adoption of health promoting behaviors and avoid
unnecessary subspecialty consults.
*Individual sessions will post topic-specific learning objectives.
Faculty and Financial Disclosures
See page 27 for a full list of program faculty and financial
disclosure information.
Education Credit
Physician Assistants:
AAPA accepts certificates of participation for educational
activities certified for AMA PRA Category 1 credit™ from
organizations accredited by ACCME. Physician assistants may
receive Certificate of Attendance for a maximum of 19 hours
of AMA PRA Category 1 credit™ for completing this program.
Nurse Practitioners:
pmiCME is approved as a provider of nurse practitioner
continuing education by the American Association of Nurse
Practitioners. AANP provider 040308. This program has been
approved for 19 contact hours of continuing education
(which includes 9.5 hours of pharmacology).
CUMULATIVE
AMA PRA Category 1
Credits™ or
AMA PRA Category 1
Credits™ or
AANP Contact Hours
(AANP Pharmacology)*
AANP Contact Hours
(AANP Pharmacology)
Morning Sessions
3 (1.5)
3 (1.5)
pmiCME is accredited by the Accreditation Council for
Continuing Medical Education to provide continuing
medical education for physicians.
Afternoon Sessions
4 (2.0)
7 (3.5)
AMA PRA Designation Statement
Day 2
Morning Sessions
3 (1.5)
10 (5.0)
Afternoon Sessions
4 (2.0)
14 (7.0)
Morning Sessions
3 (1.5)
17 (8.5)
Afternoon Sessions
2 (1.0)
19 (9.5)
Day 1
Physicians:
ACCME Accreditation Statement
pmiCME designates this live activity for a maximum of
19 AMA PRA Category 1 credits™. Physicians should claim
only the credit commensurate with the extent of their
participation in the activity.
Family Practice Physicians:
This live activity, Pri-Med Annual Conference from 09/12/14
19 prescribed credit(s) by the American Academy of Family
Physicians (AAFP).
Day 3
15
BOSTON, MA
SESSION
Please reference the green box to the left for the new
evaluation and claiming education credit process.
Annual Conference CME Information
• Enhance your ability to diagnose, treat and manage health
problems you see in your practice.
pmiCME designates the session About My Error for 1.0 credit
of Patient Safety, Risk Reduction or Risk Management. Please
check your individual state licensing board requirements
before claiming Patient Safety, Risk Reduction or Risk
Management credit.
SEPTEMBER 2014
Learning Objectives*
• Evaluate new guidelines and evidence-based practices and
therapies.
pmiCME designates the SAFE Opioid Prescribing session for
4.0 credits of Pain Management. Please check your individual
state licensing board requirements before claiming Pain
Management credit.
•
Target Audience
This program is intended for clinicians in primary care, family
medicine, pediatrics, and internal medicine.
Pain Management and Patient Safety, Risk Reduction
or Risk Management Credit:
Pri-Med East Annual Conference
September 12–14, 2014
Annual Conference CME Information
About pmiCME
Pri-Med programs are owned and operated
by DBC Pri-Med, LLC, a division of Diversified
Communications, located in Boston, Massachusetts.
The accredited provider for this program is
pmiCME, the accredited division of Pri-Med.
BOSTON, MA
•
SEPTEMBER 2014
16
Accredited by the ACCME and approved as a provider
of continuing education by the AANP, pmiCME ensures
that Pri-Med continuing education programs are highquality credited learning experiences for participants,
faculty speakers, and supporters alike. pmiCME provides
conferences, an online learning platform, and innovative
forms of distance education in order to contribute to
the continuing professional development of healthcare
providers and to influence clinical practice behaviors
for the purpose of improving health outcomes.
Academic Partnerships
pmiCME and the American College of Physicians (ACP)
gratefully acknowledge Tufts Health Care Institute as an
academic partner providing independent expert reviews
of Annual Conference educational content.
Disclosure and Conflict of Interest Resolution Policy
pmiCME requires all individuals in a position to influence
educational content for pmiCME-certified CME activities
to disclose relevant personal financial relationship(s) with
commercial interests prior to contributing to the activity.
pmiCME assesses disclosed relationships and follows a
defined process to resolve real or implied conflicts to
ensure, to the best of our ability, that all educational
content is free of commercial bias. Financial disclosures
are listed in this guidebook and will also be announced
prior to the start of each presentation and posted on
www.pri-med.com .
Discussion of Off-Label Uses and Investigational
Products
During the course of their presentations, the faculty may
mention uses of products that have not been approved
in the United States for the indication(s) being discussed.
All presenters are instructed to notify participants when
they are discussing unapproved uses or investigational
agents. In addition, specific slides will include notation
of the off-label use or investigational agent being
discussed. Views presented during this program related
to unapproved uses of products are solely those of the
presenter(s) and are not endorsed by pmiCME or DBC
Pri-Med, LLC.
Disclaimer
No part of this program syllabus may be reproduced or
otherwise incorporated into any information retrieval system
without the written permission of DBC Pri-Med, LLC. The
opinions, recommendations, and perspectives expressed in
the syllabus and accompanying presentations are those of
the faculty only and do not necessarily reflect the opinions,
recommendations, or perspectives of their affiliated institutions,
pmiCME, Diversified Communications, or commercial
supporters. Clinical judgment must guide each clinician in
weighing the benefit of any intervention or treatment against
the risk of the intervention or treatment. Dosage, indications,
and methods of use for products referred to in this program are
not necessarily the same as indicated in the package insert for
the product and may reflect the clinical experience or expertise
of the faculty speaker. Any procedures or treatments should not
be utilized without evaluation of the patients’ conditions and
or possible contraindications or risks and without a review of
any applicable product information and comparison with the
recommendations of other authorities.
ADDITIONAL
OPPORTUNITIES
TICKET BOOTH
A new ticketing policy is being implemented to give all
attendees equal opportunity to attend the additional
events within the conference, such as Presentation
Theaters and Educational Symposia. Distribution of all
additional opportunity tickets will occur at the Ticket
Booth located in the North Lobby on Level 1, on-site
on a first-come, first-served basis starting on Friday,
September 12.
The Ticket Booth is located in the North Lobby,
Level 1 and will be open during the following hours,
or until tickets are no longer available:
•
•
•
Friday, September 12: 6:45am–4:30pm
Saturday, September 13: 6:45am–4:30pm
Sunday, September 14: 6:45am–12pm
*The Ticket Booth will close once all available tickets have been distributed.
ARE YOU IN
DIRECT PRIMARY CARE?
WE’VE GOT A SMARTER
EHR SYSTEM FOR YOU.
VISIT ROOM 102A TO GET AN
EXCLUSIVE SNEAK PREVIEW OF
THE NEWEST CONCEPT IN CLINICAL
DOCUMENTATION FROM THE TEAM
AT AMAZING CHARTS AND PRI-MED.
Session Information
Primary Care Updates Track 1
Session 1 – Managing Shift
Work Disorder in Primary Care:
Overcoming Barriers to Improve
Patient Outcomes
Karl Doghramji, MD
Session Information
Education Partner: Integritas Communications
BOSTON, MA
•
SEPTEMBER 2014
18
• Describe the neurophysiologic
mechanisms of circadian rhythms and
adverse multisystem consequences of
misalignment for patient health and
function.
• Evaluate sleep patterns and symptoms
of shift work disorder using clinical tools
and strategies, such as sleep logs and the
Epworth Sleepiness Scale.
• Diagnose shift work disorder based on
identified symptoms, patient history and
work schedule, and a comprehensive sleep
history.
• Tailor therapeutic regimens for shift
work disorder that include appropriate
combinations of nonpharmacologic and
pharmacologic modalities.
• Educate patients on the potential
consequences of poorly managed shift
work disorder and the fundamentals of
sleep hygiene.
Session 2 – Applying Stroke and
Bleeding Risk Assessment in
Atrial Fibrillation to Optimize
Anticoagulation Therapy
Bruce Stambler, MD
Education Partner: Horizon CME
• Apply risk stratification strategies to
identify stroke and bleeding risk in patients
with AF.
• Review the coagulation cascade including
the role of factor Xa and thrombin in the
development of thromboembolic events.
• Summarize current evidence with available
and emerging anticoagulants for stroke
prevention in patients with AF.
• Implement guideline recommended
therapy for AF stroke prevention, taking
into account individual patient stroke and
bleeding risk.
• Apply strategies to improve patient
medication adherence and safe switching
of anticoagulant therapies.
Session 3 – Improving Outcomes
in Type 2 Diabetes: Integrating
GLP-1 Receptor Agonists into
Multimodal Treatment Regimens
Mark W. Stolar, MD
• Discuss the pathologic mechanisms of
T2DM that support the need for prompt
diagnosis and aggressive treatment.
• Identify patient-centered treatment goals
for patients with T2DM that encompass
good overall glycemic control and
improvements in other clinical parameters.
• Evaluate the clinical profiles of GLP-1
receptor agonists for the treatment of
T2DM.
• Individualize therapeutic regimens for
T2DM to maximize efficacy and minimize
hypoglycemia, weight gain, and other
potential treatment-related risks.
• Communicate with patients with
T2DM about lifestyle modifications,
antihyperglycemic options, and the need
for treatment adherence.
Session 4 – Caring for Patients
with Chronic Pain: Responsible
Opioid Prescribing to Achieve
Individualized Functional Goals
• Discuss the neurobiologic mechanisms
that underlie chronic pain and associated
functional disability.
• Assess biopsychosocial factors that
contribute to chronic pain via patient
histories, clinical interviews, and physical
exams.
• Tailor multimodal opioid-based therapy
for patients with chronic pain based on
analgesia, functional responses, adverse
events, and stratified risk of aberrant
behaviors.
• Employ opioid prescribing principles for
patient monitoring and documentation
to comply with medical standards of care,
government agencies, and risk evaluation
and mitigation strategies.
• Educate patients about the safe and
appropriate use of prescription opioid
analgesics, including common side effects,
drug-drug interactions, and the critical
need to adhere to the therapeutic plan.
Session 5 – Current Perspectives
and Emerging Approaches in
Lipid Management
Education Partner: Voxmedia, LLC
• Evaluate primary and secondary
prevention evidence with statins.
• Explain the importance of lowering LDL-C
for reducing cardiovascular risk, interpret
statin safety data, and assess benefit/risk
with statins.
• Explain the association of
hypertriglyceridemia with increased risks
and identify currently available therapies
for reducing elevated triglycerides.
• Discuss similarities and differences
between currently available and emerging
omega-3 fatty acid agents, and indicate
patient populations for potential
incorporation of omega-3 fatty acids in
clinical practice.
Primary Care Updates Track 2
Session1 – Improving Outcomes
for Acute Coronary Syndrome
Patients: Best Practices for
Primary Care Clinicians
Education Partner: Voxmedia, LLC
• Summarize fundamental similarities
and differences in pharmacokinetics,
pharmacodynamics, and
pharmacogenetics of oral antiplatelet
drugs.
• Explain efficacy and safety data with oral
antiplatelet therapies from ACS outcomes
trials.
• Recognize guideline-based therapies
to reduce risk and goals to achieve in
the management of patients who have
experienced an acute coronary syndrome.
Session 3 – The Evaluation and
Treatment of Benign Prostatic
Hyperplasia and Lower Urinary
Tract Symptoms in the Primary
Care Setting
Martin Miner, MD
Education Partner: Miller Medical Communications, LLC
• Describe the pathophysiology and
common comorbidities of BPH/LUTS.
• Implement comprehensive assessment of
patients with BPH/LUTS.
• Select treatment options available to
effectively treat BPH/LUTS.
Session 4 – Against All Odds:
Improving Insulin Use in T2DM
through Individualized Clinical
Decision Making
Frank Lavernia, MD
Education Partner: Vindico Medical Education
• Summarize the clinical evidence
supporting the use of basal insulin therapy,
with and without GLP-1 receptor agonists,
in the management of type 2 diabetes.
• Incorporate strategies to overcome barriers
to insulin use in the treatment of type 2
diabetes.
Pri-Med, in collaboration with American
College of Physicians, has received
commercial support for the SAFE Opioid
Prescribing training provided by an
educational grant from the REMS Program
Companies. This educational activity is
supported by an independent educational
grant from the ER/LA Opioid Analgesic
REMS Program Companies (RPC). Please see
www.er-la-opioidREMS.com for a listing of
the member companies. This activity is fully
compliant with the ER/LA Opioid Analgesics
REMS education requirements issued by the
U.S. Food and Drug Administration (FDA).
• Effectively assess and diagnose patients
with common community-acquired
infections
• Apply the latest guideline
recommendations for appropriate
treatment of pharyngitis, urinary tract
infection, and cellulitis
Annual Conference
Hall B
The Future of Medicine
Daniel Kraft, MD
• Discuss future technologies that will
impact healthcare and medicine.
• Understand key challenges of healthcare
today and how emerging and exponential
technologies can improve healthcare
delivery and population health.
• Review some of the technologies that are
helping to transform healthcare.
SAFE Opioid Prescribing:
Evaluation Is Essential for Safe
and Effective Pain Management
Using ER/LA Opioids
Charles Argoff, MD
• Identify risk factors for opioid-related
aberrant behavior.
• Differentiate between tolerance, physical
dependence, and addiction.
Targeting Better Cardiac
Outcomes for High-Risk Patients
SAFE Opioid Prescribing: Best
Practices for How to Start
Therapy with ER/LA Opioids,
How to Stop, and What to Do in
Between
Jeffrey Gudin, MD
• Evaluate recent clinical trials with respect
to management of low HDL.
• Examine the data on triglycerides and CVD
risk to determine how aggressively to treat
patients with elevated TGs.
• Employ strategies for reducing CVD risk
in patients with type 2 diabetes and
hypertension.
Understanding Dyslipidemia
Testing and Screening:
Importance of Lipoprotein
Particle Analysis
• Describe the pathogenesis of
dyslipidemias in patients with diabetes and
chronic kidney disease.
• Understand the rationale for performing
lipoprotein particle analysis in patients
with high CV risk comorbidities.
• Convert patients from immediate-release
to ER/LA opioids as well as from one ER/LA
opioid to another.
• Identify predisposing risk factors for
significant respiratory depression.
Evidence-Based Tools for
Screening for Patients at Risk
and Monitoring for Adherence to
Prescribed ER/LA Opioids
Jeffrey Gudin, MD
• Evaluate and manage adverse effects of
ER/LA-opioids.
• Differentiate strategies for monitoring
patient adherence.
19
SEPTEMBER 2014
• Recognize 2012 ACR guidelines for treating
and managing acute and refractory gout.
• Integrate into their current practice
paradigms current recommendations
for lowering urate levels, treating
inflammation, and preventing joint
destruction.
• Develop counseling, education, and
practice management strategies that
promote better patient adherence to longterm therapies for gout.
• Implement current recommendations to
prevent and treat gout flares.
•
Education Partner: DKBmed
|Strategies. Assessment.
Fundamentals. Education
BOSTON, MA
Michael H. Pillinger, MD
Session 5 – Current Approaches
to Infectious Diseases in Primary
Care
Session 2 – Gout: Optimizing
Disease Management 2014
Session Information
Session Information
Session Information
SAFE Opioid Prescribing: Talk to
Me: Proven Methods to Counsel
Your Patients on ER/LA Opioids
and Achieve Positive Outcomes
Michael Brennan, MD, FACP, FASAM
• Implement counseling strategies to ensure
patients know to take ER/LA opioids
exactly as prescribed.
• Use counseling strategies to explain signs
of ER/LA opioid overdose to patients and
caregivers.
Everything You Always Wanted to
Know about ER/LA-Opioids as a
Drug Class
Session Information
Michael Brennan, MD, FACP, FASAM
20
SEPTEMBER 2014
•
BOSTON, MA
Test Your Skills in Difficult Cases:
Atrial Fibrillation
Victor Rao, MBBS, DMRD, RDMS
Michael Wagner, MD
Keith Barron, MD
Kent R. Nilsson, MD, FACC
• Understand the defining characteristics of
point-of-care or the focused ultrasound
examinations.
• Identify how point-of-care ultrasound can
be used to diagnose and manage heart
failure, abdominal pain, musculoskeletal
pain, and soft-tissue infections.
*Insulin Therapy in Patients with
Type 2 Diabetes: Current and
Emerging Basal Insulins
• Assess the differences in opioid
metabolism and how these impact
appropriate ER/LA prescribing.
• Identify how opioid-drug interactions
influence ER/LA opioid prescribing.
Education Partner: Horizon CME
SAFE Opioid Prescribing: Getting
the Most Clinical Insights
from Specific ER/LA Product
Information Sources
Charles Argoff, MD
• Differentiate the prescribing information
among available ER/LA opioids.
• Identify ER/LA opioids and dosages
indicated for opioid-tolerant patients only.
Medical Brain Game: SAFE Opioid
Prescribing Edition
Introduction to Ultrasound and
Case Presentations
Charles Argoff, MD; Michael Brennan, MD,
FACP, FASAM; Jeffrey Gudin, MD
Grand Ballroom
• Outline the benefits of early insulin therapy
in patients with type 2 diabetes.
• Discuss when insulin may be initiated
for the treatment of patients with type 2
diabetes.
• Describe the advantages and
disadvantages of various insulin regimens
and apply them in clinical practice for the
selection and titration of insulin in patients
with type 2 diabetes.
• Identify the barriers to insulin-mediated
glucose control and apply strategies to
overcome them.
• Describe how improved pharmacokinetic
and pharmacodynamic profiles
of emerging insulins may reduce
hypoglycemia and optimize insulin
administration.
Engaging e-Patients: How
e-Messaging, Personal Health
Records, and Patient Activation
Can Transform Your Practice
Ultrasound for the PCP
• Identify the technology that has made
ultrasound accessible to primary care
providers.
• Identify three advantages of offering
ultrasound in the primary care setting.
• Identify three clinical applications of pointof-care ultrasound in primary care.
• Describe current guidelines and
clinical evidence regarding the use of
anticoagulant therapy in patients with
atrial fibrillation (AF).
• Differentiate between rate and rhythm
control in AF and direct appropriate
treatment strategies based on these
parameters.
Tips for Managing Behavioral
Issues in Elderly Patients with
Dementia
• Differentiate the variation in symptoms of
the dementing disorders, depending upon
their etiology.
• Apply appropriate pharmacological
therapies for behavioral problems
associated with dementia.
• Apply appropriate nonpharmacological
therapies for agitation, with special
attention to the environment.
Ultrasound Workshops Room 205A
Richard Hoppmann, MD, and University
of South Carolina School of Medicine
Ultrasound Institute faculty
• Identify the essential features of portable
ultrasound systems.
• Understand important practical principles
of ultrasound image acquisition.
• Learn how to perform basic point-of-care
ultrasound examinations of the neck, the
heart, the abdomen, and the knee.
• Learn how to perform ultrasound guided
procedures.
Daniel Z. Sands, MD, MPH
• Take advantage of online resources to
expand your medical knowledge and
augment your clinical expertise.
• Provide practical advice to patients about
smart and appropriate use of web-based
health information and social media.
* Indicates Primary Care Updates Session
Session Information
• Understanding the health benefits
of laughter such as: immune system
enhancement, pain management, stress
hormone reduction
• Implement workplace benefits of laughter
such as: team unity, productivity, creativity
Obstructive Sleep Apnea:
Interventions That Will Help Your
Patients Sleep Better
Jonathan Lown, MD
• Implement practice-based procedures to
screen and manage patients at risk for or
with evidence of obstructive sleep apnea.
• Co-manage patients with OSA and
encourage continued monitoring and
compliance with CPAP therapy.
New Insights into Reducing
CV Risk in Patients with Type 2
Diabetes
• Identify key factors associated with
increased cardiovascular outcomes in
patients with type 2 diabetes.
• Implement current evidence-based
guidelines to reduce the risk of CV disease
in patients with type 2 diabetes mellitus.
Grand Ballroom
Infectious Diseases Update in
Primary Care
VTE Prevention: Avoiding the
Avoidable in Medical and HighRisk Patients
Gregory Piazza, MD
• Identify high-risk medical and hospitalized
patients for whom thromboprophylaxis
should be initiated.
• Determine appropriate oral regimens
for extended thromboprophylaxis after
hospital discharge.
Live Demonstration Orthopedic
Exam: See It, Do It
• Through live demonstration of orthopedic
maneuvers, you will improve your ability
to diagnose common musculoskeletal
complaints of the upper body, low back,
hip, and knee.
• Apply current clinical guidelines to the
diagnosis and treatment of acute bacterial
sinusitis.
• Differentiate the diagnosis of latent
tuberculosis infection from that of active
tuberculosis.
• Apply current evidence and guidelines to
the clinical management of genital herpes.
Fighting a Growing Epidemic: A
Viral Hepatitis Update
Nancy Reau, MD
• Assess updated guidelines for screening
and evaluating patients for HCV in the
primary care setting.
• Direct antiviral therapy for HCV and HBV
using best available evidence.
• Monitor patients for antiviral treatment
response and toxicities.
Education Partner: CE Health Interactive
• Recognize the role of the renal system
in glucose uptake, reabsorption, and the
maintenance of glucose homeostasis, and
use the achieved knowledge to identify
patients who would benefit from renallytargeted therapies.
• Explain the mechanism of action of
sodium glucose linked transporter
inhibitors and their role in modulating
glucose homeostasis.
• Review professional guidelines from the
ADA and AACE for target goals of therapy
and treatment recommendations for
specific patient-types.
• Identify the safety and efficacy profiles of
current and emerging therapies that target
renally-mediated glucose uptake and
reabsorption.
• Implement management strategies
that incorporate current and emerging
therapies into treatment paradigms
for patients who would benefit from a
targeted approach to glycemic control.
Medical Brain Game 2014: PCP
Edition
M. Susan Burke, MD, FACP, and Katherine
Galluzzi, DO, FACOFP, CMD
Session Information
Laughter Is the Best Medicine
• Utilize evidence-based lipoprotein
management strategies for non-LDL-C lipid
targets.
• Describe the risk factors, disease spectrum,
and appropriate management of familial
hypercholesterolemia.
21
• Compete in the popular yet practical
medical knowledge game. New categories
are sure to provide a fun challenge.
The Problem Pests: Ticks, Mites,
Bed Bugs, and Lice
Stephen Gluckman, MD, FACP
• Differentially diagnose common tickborne diseases, using symptomology,
epidemiologic evidence, and lab tests, and
prescribe antibiotic therapy as indicated.
• Diagnose and manage clinical
manifestations of common pest
infestations, including lice, mites, and
bedbugs.
* Indicates Primary Care Updates Session
SEPTEMBER 2014
Hall B
•
Alan Brown, MD, FACC, FNLA, FAHA
BOSTON, MA
*Addressing Renal-Mediated
Glucose Homeostasis: Diabetes
and the Kidney
Lipid Management: A Primary
Care Perspective
Annual Conference
Session Information
Critical Caveats for Common
Medications
Practical Approaches to the
“Dizzy” Patient
Hot off the Press and into Your
Practice 2014
Douglas S. Paauw, MD
Marie Brown, MD, FACP
• Effectively manage patients who are on
statin therapy with respect to potential
drug interactions and muscle-related
symptoms.
• Consider potential adverse effects of
proton pump inhibitors, such as impaired
absorption of certain nutrients, when
prescribing as long-term therapy.
• Consider the potential etiologies for
symptoms of lightheadedness or vertigo.
• Determine appropriate next steps, such
as testing, referral, or treatment based on
clinical assessment.
• Consider key findings from important new
studies that can change your patient care.
About My Error
Ali Assefi, MD
Annual Conference
• Detail how to prepare for error in the
clinical setting and how to handle an error
when it occurs.
• Outline how systems decrease the
probability of error in order to effect
practice-based changes that reduce
clinical errors.
• Create in your practice setting a culture of
safety, rather than shame and blame, with
respect to the management of clinical
errors.
Sunday, September 14, 2014
Session Information
Hall B
BOSTON, MA
•
SEPTEMBER 2014
22
Obesity in America from the
Dietary Counselor and Lifestyle
Coach from The Biggest Loser
• Employ proven, evidence-based lifestyle
and behavioral modalities to help your
obese patients lose weight and achieve
health benefits.
In Search of Joy in Practice:
Innovations in Patient-Centered
Care
Christine Sinsky, MD, and
Thomas Sinsky, MD
• Identify three innovations to improve
quality and satisfaction of practice.
• Integrate cost-effective innovations into
your practice.
Lung Sounds: A Primer on
Pulmonary Auscultation
• Recognize and identify various breath
sounds and adventitious lung sounds,
including those findings that have been
described only recently.
• Link literature validation and scientific basis
to those sounds and extra-sounds that are
clinically relevant.
• Establish a clinico-pathologic correlation
for sounds and extra-sounds and
murmurs.
David Ring, MD, PhD
Optimizing the Management
of Patients with Chronic Kidney
Disease
• Understand the impact of chronic kidney
disease (CKD) as a common condition of
the adult US population.
• Apply the latest evidence-based
recommendations for diagnosis and
management of patients with stages 1-3
CKD.
• Slow CKD progression by treating risk
factors such as hypertension and diabetes.
Grand Ballroom
Women’s Health Update:
Clinical Pearls for Primary Care
Kelly Anne Spratt, DO, FACC, FACP
• Weigh the evidence for benefit versus
harm when considering hormone
replacement therapy for women with
menopausal symptoms.
• Proactively screen and treat elderly
women to prevent falls and fractures.
Improve Patient Outcomes
with Effective Diagnosis and
Treatment of Underlying
Psychiatric Disorders
Rosalind Kaplan, MD, FACP
• Recognize the signs and symptoms of
major depressive disorder (MDD) and
initiate therapy with close monitoring.
• Differentiate bipolar disease from
symptoms of depression in order to
determine appropriate treatment.
• Consider actions and side effects of drugs
and drug classes when deciding on which
treatment to select for patients with
psychiatric disorders.
Clinicians Love
Amazing Charts
Here are some
reasons why...
“Amazing Charts is so easy to use that we actually get home for dinner.
Our kids can’t believe it!”
– Drs. Jennifer and David Benson, Family Medicine
“As a provider, I felt comfortable switching from our former EHR to Amazing Charts.
They were very responsive to any issues we had during our transition.”
– Dr. Vishal Datta, Endocrinology
“Unlike other EHRs, Amazing Charts actually lets me have more
face-to-face time with patients.”
Booth
#1415
– Dr. James Legan, Internal Medicine
Start your FREE trial today!
amazingcharts.com/trial
866-382-5932
Faculty Information
Professor of Medicine
Director, Harold Schnitzer Diabetes Health Center
Oregon Health & Science University
Portland, OR
Charles E. Argoff, MD
Professor of Neurology, Albany Medical College
Director, Comprehensive Pain Center, Albany Medical Center
Albany, NY
Ali R. Assefi, MD
Assistant Clinical Professor of Medicine
Georgetown University Medical School
Washington, DC
Chief, Renal Section, Inova Fairfax Hospital
Falls Church, VA
Keith Barron, MD
Chief Resident, UofSC School of Medicine,
Primary Care Ultrasound Fellow at USC, University
of South Carolina School of Medicine
Columbia, SC
Faculty Information
Director, Ochsner Diabetes Clinical Research Unit
Department of Endocrinology, Diabetes and Metabolism
Associate Internal Medicine Residency Program Director
Ochsner Medical Center
New Orleans, LA
24
The Medical Director, The Pain Center of Fairfield
Fairfield, CT
Senior Attending Physician
Department of Medicine
Bridgeport Hospital
Bridgeport, CT
Director
Atherometabolic Research
Utah Foundation for Biomedical Research
Salt Lake City, UT
Alan S. Brown, MD, FACC, FNLA, FAHA
Clinical Associate Professor of Medicine
Stritch School of Medicine
Loyola University
Director, Division of Cardiology
Advocate Lutheran General Hospital
Director, Midwest Heart Disease Prevention Center
Midwest Heart Specialists-Advocate Medical Group
Chicago, IL
BOSTON, MA
•
SEPTEMBER 2014
Marie T. Brown, MD, FACP
Assistant Professor of Medicine
Department of Internal Medicine
Rush University Medical Center
Governor, Illinois-N Chapter
American College of Physicians
Operations Committee
National Diabetes Education Program
Chicago, IL
M. Susan Burke, MD, FACP
Clinical Associate Professor
Thomas Jefferson University Medical School
Adjunct Associate Professor of Geriatrics
Philadelphia College of Osteopathic Medicine
Senior Advisor, Lankenau Medical Associates
Lankenau Medical Center
Philadelphia, PA
Christopher Cooper, MD
Professor of Medicine and Physiology
David Geffen School of Medicine
University of California, Los Angeles
Los Angeles, CA
Baldino Professor of Sleep Medicine
Director, Division of Sleep Medicine
Harvard Medical School
Chief, Division of Sleep and Circadian Disorders
Departments of Medicine and Neurology
Brigham and Women’s Hospital
Boston, MA
Assistant Professor, Medicine
Northwestern University Feinberg School of Medicine
Chicago, IL
Karl Doghramji, MD
Professor of Psychiatry, Neurology, and Medicine
Medical Director, Jefferson Sleep Disorders Center
Program Director, Fellowship in Sleep Medicine
Thomas Jefferson University
Philadelphia, PA
Family Physician
Collegeville Family Practice
Medical Director of Health Services
Ursinus College
Collegeville, PA
Dean Emeritus
Director, Ultrasound Institute
Dorothea H. Krebs Endowed Chair of Ultrasound Education
University of South Carolina School of Medicine
Columbia, SC
Professor of Clinical Medicine
University of Miami
Past President,
American College of Endocrinology (ACE)
Past President,
American Association of Clinical Endocrinologists (AACE)
The Center for Diabetes & Endocrine Care
Hollywood, FL
Rosalind D. Kaplan, MD, FACP
Associate Professor of Clinical Medicine
Temple University School of Medicine
Director, Temple Health Women’s Care
Philadelphia, PA
Frank Lavernia, MD
Founder
North Broward Diabetes Center
Deerfield Beach, FL
Instructor
Assistant Physician
Massachusetts General Hospital
Boston, MA
Jonathan Lown, MD
Associate Professor of Medicine
Director, Cardiovascular Wellness Program
Boston, MA
Clinical Assistant Professor of Medicine
Stony Brook University
Diplomate of Sleep Medicine
Stony Brook, NY
Jefferson Medical College
Philadelphia, PA
Professor of Medicine and Pharmacology
Tullis–Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Tulane University Health Sciences Center
New Orleans, LA
Adjunct Assistant Clinical Professor
University of California, San Diego School of Medicine
Founder, Chronic Pain Management Program
Kaiser Permanente San Diego
Family Practitioner
Neighborhood Health
San Diego, CA
Professor and Chairperson, Department of Geriatric Medicine
Director, Comprehensive Care
Philadelphia College of Osteopathic Medicine
Medical Director, Hospice of Philadelphia
VNA of Greater Philadelphia
Philadelphia, PA
Boston, MA
Martin Miner, MD
Clinical Professor of Medicine
Emory University School of Medicine
CEO & Chief Medical Officer
Healing Our Village, Inc.
Fayetteville, GA
Chief of Primary Care and Community Medicine
The Miriam Hospital
Co-Director
Men’s Health Center
Clinical Associate Professor of Family Medicine and Urology
Warren Alpert Medical School
Brown University
Providence, RI
Stephen J. Gluckman, MD, FACP
Perelman School of Medicine
University of Pennsylvania
Medical Director
Penn Global Medicine
Philadelphia, PA
Director-Complex Ablations, Athens Regional Medical Center
University of Georgia/Georgia Regents University
Athens, GA
Director, Pain and Palliative Care
Englewood Hospital and Medical Center
Englewood, NJ
Rothman Family Foundation
Endowed Chair in Patient-Centered Clinical Education
University of Washington School of Medicine
Seattle, WA
Kalpana Gupta MD, MPH
Gregory Piazza, MD
Jeffrey Gudin, MD
Boston University School of Medicine
Boston, MA
Instructor of Medicine
Staff Physician
Cardiovascular Division
Boston, MA
Faculty Information
NYU School of Medicine
Section Chief, Rheumatology
New York Harbor VA Healthcare System
New York, NY
Assistant Professor
TIMI Study Group
Boston, MA
Professor, Sanford Burnham Medical Research Institute
Senior Scientist
Florida Hospital Sanford Burnham Translational
Research Institute, Orlando, FL
Victor V. Rao, MBBS, DMRD, RDMS
Professor of Neurology
Director, Clinical Neurophysiology Laboratories
Director, Neuromuscular Division
Director, Neuro-AIDS Program
Mount Sinai Medical Center
New York, NY
Director of Ultrasound Education
University of South Carolina School of Medicine Ultrasound
Institute
Columbia, SC
Christine Sinsky, MD
Nancy Reau, MD
Thomas Sinsky, MD
University of Chicago, Chicago, IL
David C. Ring, MD, PhD
Chief, Hand and Upper Extremity Service
Director of Research, Hand and Upper Extremity Service
Associate Professor of Orthopaedic Surgery
Boston, MA
Medical Director
Mid-Michigan Health Centers
Chief, Department of Family Medicine
Foote Health System
Jackson, MI
Associate Director, Bucksbaum Institute
for Clinical Excellence
University of Chicago School of Medicine
Chicago, IL
Kelly Anne Spratt, DO, FACC, FACP
Clinical Associate Professor of Medicine
University of Pennsylvania
Philadelphia, PA
Bruce Stambler, MD
Director of Cardiac Arrhythmia Research and Education
Piedmont Heart Institute
Atlanta, GA
Mark W. Stolar, MD
General Internist
Medical Associates Clinic and Health Plans
Dubuque, IA
Associate Professor
Northwestern University Feinberg School of Medicine
Attending Physician
Northwestern Memorial Hospital
Chicago, IL
Michael Wagner, MD
Division of General Medicine and Primary Care
Beth Israel Deaconess Medical Center
Boston, MA
Physician, University of Pennsylvania Health System
Preventive Cardiovascular Medicine
Penn Medicine at Radnor
Perelman Center for Advanced Medicine
Philadelphia, PA
Attending Physician, Beth Israel Deaconess Medical Center
Boston, MA
Senior Physician
Joslin Diabetes Center
Boston, MA
Primary Care Ultrasound Fellow
University of South Carolina School of Medicine
Columbia, SC
Emily Wan, MD
Instructor
Attending
Brigham & Women’s Hospital
25
Exhibitor Information
SEPTEMBER 2014
Interactive Floor Maps
Session and Faculty Information
Personalized Planner
•
Social Media Connections
The Pri-Med East App has a powerful search engine,
planning tools, and interactive maps to make it
easy to get the most out of your time, discover
new products, navigate the Exhibit Hall and stay
up-to-date on all program-related news and events.
BOSTON, MA
Up-to-the-Minute Conference Updates
PRI-MED MOBILE APP IS A FREE DOWNLOAD
FOR ANDROID, IPHONE, AND BLACKBERRY
SEARCH FOR PRI-MED EST
General Internist
Medical Associates Clinic and Health Plans
Dubuque, IA
Faculty Information
Primary Care
Updates Faculty
Consultant for Novo Nordisk and Medtronic.
Speakers Bureau member for Allergan, Inc., Depomed, Inc., Janssen Pharmaceuticals, Inc., Millennium Laboratories, LLC, and XenoPort, Inc.;
Advisory Board member for Acorda Therapeutics, Inc., AstraZeneca Pharmaceuticals LP, Depomed, Inc., Insys Therapeutics Inc., Nektar
Therapeutics, Pfizer Inc., Purdue Pharma L.P., QRX Pharma Ltd., Teva Pharmaceuticals Industries Ltd., and XenoPort, Inc.; Receives research
support from Eli Lilly and Company, Endo Pharmaceuticals Inc., and Forest Laboratories, Inc.
Lawrence Blonde, MD
Research support from Eli Lilly and Company, Novo Nordisk A/S and sanofi-aventis US LLC. He receives honoraria for his role as a speaker
from AstraZeneca, Janssen Pharmaceuticals, Inc., Merck & Co., Novo Nordisk A/S, and sanofi-aventis US LLC. He receives honoraria for his role
as a consultant to AstraZeneca, GlaxoSmithKline, Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Novo Nordisk A/S, Quest Diagnostics, and
sanofi-aventis U.S. LLC.
Advisory Board member for Insys Therapeutics Inc., Mallinckrodt Pharmaceuticals, Purdue Pharma L.P., Teva Pharmaceuticals Industries Ltd.,
and Zogenix, Inc.
Christopher Cooper, MD Receives grant research support from Aeris Therapeutics; consultant fees from Boehringer Ingelheim, PulmonX, Spiration, eResearch
Technology, and Equinox. He is on the speakers bureau for Boehringer Ingelheim, GlaxoSmithKline, Forest Pharmaceuticals, and Pfizer.
Consultant for Bombardier, Inc., Teva Pharmaceuticals, Novartis Pharmaceuticals Corporation, Purdue Pharma, Vanda Pharmaceuticals, Inc.,
and Zeo, Inc. Received research support from Cephalon, Inc., Philips Respironics, and ResMed Inc. Owns stock in Lifetrac, Inc., Somnus
Therapeutics Inc., and Vanda Pharmaceuticals Inc.
Karl Doghramji, MD
Consultant for Aptalis, Jazz Pharmaceuticals plc, and Vanda Pharmaceuticals Inc.; Owns stock in Merck & Co., Inc.
Speakers Bureau and Advisory Board member for Teva Pharmaceutical Industries, Ltd.
Received investigator initiated support from Novartis.
JoAnne M. Foody, MD, FACC, FAHA No financial relationships to disclose
Receives grant research support via Tulane University from Abbott Laboratories; Eli Lilly and Company; GI Dynamics, Inc.; Novo Nordisk A/S;
Pan American Laboratories; Reata Pharmaceuticals Inc.; and sanofi-aventis U.S. LLC. Receives honoraria for consulting and lectures from
Abbott Laboratories; AstraZeneca; Boehringer Ingelheim GmbH; Bristol-Myers Squibb Company; Daiichi Sankyo Company, Limited; Eli Lilly
and Company; GlaxoSmithKline; Janssen Pharmaceuticals, Inc.; Novo Nordisk A/S; PamLab, Inc.; sanofi-aventis U.S. LLC; and Takeda
Pharmaceuticals U.S.A., Inc.
Speakers Bureau member for Janssen Pharmaceuticals, AstraZeneca, and Boehringer Ingelheim.
Receives fees for non-CME/CE services for UpToDate, Inc. Consulting fees from Boehringer Ingelheim GmbH and Melinta Therapeutics. She
and her spouse hold an ownership interest in Sarepta Therapeutics, Inc, Seattle Genetics, Antares Pharma, Inc, and Novartis. Spouse is
employed by Novartis Corporation.
Speaker and receives honoraria from Boehringer Ingelheim, Janssen Pharmaceuticals, and Novo Nordisk.
Frank Lavernia, MD
Advisory Board member for Janssen Pharmaceuticals and Sanofi-Aventis.
Advisory Board member for AstraZeneca Pharmaceuticals LP, Collegium Pharmaceutical, Inc., Depomed, Inc., Inspirion Pharmaceuticals, LLC,
Iroko Pharmaceuticals, LLC, Janssen Pharmaceuticals, Inc., Kaléo, Inc., Mallinckrodt Pharmaceuticals, Millennium Laboratories, LLC, Pfizer Inc.,
Salix Pharmaceuticals, Inc., Takeda Pharmaceuticals U.S.A., Inc., and Zogenix, Inc.; Owns stock in BioSpecifics Technologies Corp., Galena
Biopharma, Inc., Johnson & Johnson, Nektar Therapeutics, and Protein Design Labs, Inc.
Affiliated with the TIMI Study Group and Brigham and Women’s Hospital, which have received clinical research grants or research supplies
from Accumetrics, AstraZeneca, Bayer Healthcare, Bristol-Myers Squibb, Daiichi Sankyo, Eli Lilly, Johnson & Johnson, Nanosphere, and SanofiAventis. Consultant for American Genomics and WebMD.
Martin Miner, MD
Receives consultant honoraria from AbbVie and research funding from Forest.
SEPTEMBER 2014
Medical Advisory Board for Crealta, Inc., has done contracted research for Takeda Pharmaceutical Company, and received investigator
initiated grants from Takeda Pharmaceutical Company and Savient Pharmaceuticals.
Research grants from Gilead Sciences, Elli Lilly, Novo Nordisk, Sanofi-Aventis, and Takeda. Speakers Bureau member for Elli Lilly, Merck, Novo
Nordisk, and Takeda. Receives honoraria from AstraZeneca/BMS, Boehringer Ingelheim, GlaxoSmithKline, Janssen Pharmaceuticals Ltd., Elli
Lilly, Merck, Novo Nordisk, Sanofi-Aventis, and Takeda. Consultant for AstraZeneca/BMS, Boehringer Ingelheim, Gilead Sciences,
GlaxoSmithKline, Janssen Pharmaceuticals Ltd., Elli Lilly, Merck, Novo Nordisk, Sanofi-Aventis, and Takeda.
•
Davida F. Kruger, MSN, APN-BC, BC-ADM Honoraria for serving on Advisory Boards for Dexcom, Takeda Pharmaceutical Company, Abbott Laboratories, Janssen Pharmaceuticals, Eli
Lilly, and Novo Nordisk; Speakers’ Bureaus for Valeritas, Janssen Pharmaceuticals, Novo Nordisk, AstraZeneca/Bristol-Myers Squibb Diabetes,
and Boehringer Ingelheim.
Receives consultant and speaker honoraria from Astellas, Eisai, Ferring, Forest, Horizon, Ortho-McNeil, Lilly, and Pfizer.
BOSTON, MA
Research support via the TIMI study and Brigham and Women’s Hospital from AstraZeneca and Bristol-Myers Squibb, Daichi-Sankyo,
GlaxoSmithKline, Johnson and Johnson, Bayer Healthcare, Gilead, Eisai, and Merck. Consults for Gilead, Lexicon, Arena, Eisai, St. Jude’s Medical,
Forest Pharmaceuticals, Bristol-Myers Squibb, Boston Clinical Research Institute, Decision Resources, University of Calgary, Elsevier Practice
Update Cardiology.
David M. Simpson, MD, FAAN Is a member of the Advisory Boards for Acorda Therapeutics, Inc., Allergan, Astellas Pharma, Merz Pharmaceuticals, Inc.
Bruce Stambler, MD
Medical Advisory Board member for Boston Scientific; Speakers Bureau member for Pfizer and Bristol-Myers Squibb; Consultant for Janssen
and Medtronic. Publication-related financial support from Pfizer and Bristol-Myers Squibb.
Mark Stolar, MD
Receives honoraria for his role as a speaker and advisory board member from AstraZeneca and Takeda Pharmaceuticals USA, Inc.
No financial relationships to disclose
Emily Wan, MD
No financial relationships to disclose.
26
Primary Care Updates Planning and Review Disclosures
Nonfaculty contributors to education content planning, development, clinical editing and review for Primary Care Updates representing pmiCME (including staff, advisory boards,
consultants, and contractors); the American College of Physicians; CE Health; DKBmed; Horizon CME; Integritas Communications; Miller Medical Communications, LLC; Vindico
Medical Education; Voxmedia, LLC; and Tufts Healthcare Institute have nothing to disclose.
Speakers Bureau member for Allergan, Inc., Depomed, Inc., Janssen Pharmaceuticals, Inc., Millennium Laboratories, LLC, and XenoPort, Inc.;
Advisory Board member for Acorda Therapeutics, Inc., AstraZeneca Pharmaceuticals LP, Depomed, Inc., Insys Therapeutics Inc., Nektar Therapeutics,
Pfizer Inc., Purdue Pharma L.P., QRX Pharma Ltd., Teva Pharmaceuticals Industries Ltd., and XenoPort, Inc.; he also receives research support from Eli
Lilly and Company, Endo Pharmaceuticals Inc., and Forest Laboratories, Inc.
Ali R Assefi, MD
Speakers Bureau member and receives fees for non-CME/CE services from Amgen, Arbor, Questcor, and Takeda. Contracted research from
Amgen, Keryx, Abbvie, Nephrogenix, and Lilly.
Advisory Board member for Insys Therapeutics Inc., Mallinckrodt Pharmaceuticals, Purdue Pharma L.P., Teva Pharmaceuticals Industries Ltd., and
Zogenix, Inc. Consultant for Aegerion Pharmaceuticals, Kowa Pharmaceuticals America, Inc., and Merck & Co., Inc.
Marie T. Brown, MD, FACP
Spouse receives grant support from Abbott, BSC, Edwards, St. Jude, and WL Gore. Consultant for Abbott, BSC, Coherex, Edwards, Intervalve,
Daiichi Sankyo-Lilly, and WL Gore. Speaker for Boston Scientific.
Alan S. Brown, MD, FACC, FNLA, FAHA
Speaker for Merck, Regeneron, and Amarin. Advisory Board member for Merck and AstraZeneca. Contracted Research for Cleveland Clinic
Foundation for Strength Study National Coordinator.
M. Susan Burke, MD, FACP
Speaker for Merck and Co., Inc.
JoAnne M. Foody, MD, FACC, FAHA No financial relationships to disclose
Stephen J. Gluckman, MD, FACP
Jeffrey Gudin, MD
Speakers Bureau member for Mallinckrodt, Slix, Teva, Xenoport, Iroko, DeponiedPurdue; Medical Advisory Board member for Insys, Teca, Irokol;
consultant for Alere, Mektar; non-CME service fees from AstraZeneca and Pfizer.
Kalpana Gupta, MD, MPH Receives fees for non-CME/CE services for UpToDate, Inc. Consulting fees from Boehringer Ingelheim GmbH and Melinta Therapeutics. She and
her spouse hold an ownership interest in Sarepta Therapeutics, Inc, Seattle Genetics, Antares Pharma, Inc, and Novartis. Spouse is employed by
Novartis Corporation.
Rosalind D. Kaplan, MD, FACP
Daniel Kraft, MD
Speaker for nonmedical speaking bureaus; Medical Advisory Board member for Scanadu, Jointly, Morpheus Medical, and QualComm Life;
Stock options and patent holder in RegenMed Systems and Bioniq Health.
Jonathan Lown, MD
Medical Advisory Board for Janssen Pharmaceuticals. Consultant for Janssen and ORBIT registry.
Gregory Piazza, MD
Research grant support from Daichii Sankyo, Bristol-Myers Squibb, BTG, and Janssen; spouse is employed by Boston Scientific.
Victor Rao, MBBS, DMRD , RDMS
Nancy Reau, MD
Medical Advisory Board for Abbvie, Gilead, Idenix, and Janssen; contracted research support from Gilead, BI, BMS, Abbvie, and Janssen.
David C. Ring, MD, PhD
Grant support from Skeletal Dynamics and Biomet; consultant for Wright Medical, Skeletal Dynamics, Acumed, and Biomet; speaker for AO
North America and AO International; royalties from Wright Medical, Medartis, Skeletal Dynamics, and Biomet; holds stock options in Illuminos.
Consultant for Kinergy Health, Conversa Health, SeniorLink, and Best Doctors; ownership interest in Conversa Health.
Christine Sinsky, MD
Consultant for the American Medical Association
Thomas Sinsky, MD
Consultant for the American Medical Association
Kelly Anne Spratt, DO, FACC, FACP No financial relationships to disclose
Michael Wagner, MD
27
Carolyn Skowronski, PharmD, pmiCME, owns stock in Merck. No other nonfaculty contributors to planning, content development, and editing and review of content for the National
Meeting representing pmiCME (including staff, advisory boards, consultants, and contractors), American College of Physicians, and Tufts Healthcare Institute have nothing to disclose.
Annual Meeting Planning and Review Disclosures
BOSTON, MA
•
Keith Barron, MD Financial Disclosures
SEPTEMBER 2014
Annual Conference
Faculty
Exhibitors by Alphabetical Listing
A Fashion Hayvin, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1508
CryoSurgery, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1030
AbbVie. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1925
Dannon Company . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2109
AbbVie. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2125
Aegis Sciences Corporation. . . . . . . . . . . . . . . . . . . . . . . 1612
Darco International. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2213
www.conventionjewelry.com
www.abbvie.com
www.aegislabs.com
Akrimax Pharmaceuticals LLC. . . . . . . . . . . . . . . . . . . . . 1027
Exhibitor Information and Maps
www.akrimax.com
Alkermes Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1632
Alzheimer's Association . . . . . . . . . . . . . . . . . . . . . . . . . . 1009
Amazing Charts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1415
www.amazingcharts.com
Diva International Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1715
www.divacup.com
Docnet. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1024
www.docnet.com
Doximity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1418
www.doximity.com
Eisai, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1425
www.eisai.com
American Occupational Therapy Association. . . . . . 2113
Federal Bureau of Prisons. . . . . . . . . . . . . . . . . . . . . . . . . 2215
AndaMEDS. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1223
Argyll Diagnostics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1112
AspirinWorks by Corgenix. . . . . . . . . . . . . . . . . . . . . . . . . 1021
Forest Pharmaceuticals, Inc.. . . . . . . . . . . . . . . . . . . . . . . 1125
www.latexallergyresources.org
www.aota.org
www.corgenix.com
Astellas Pharma U.S., Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . 1829
www.astellas.com
AstraZeneca. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1218
Auxilium Pharmaceuticals, Inc.. . . . . . . . . . . . . . . . . . . . 1713
www.Auxilium.com
www.Auxilium.com
Bankers Healthcare Group, Inc.. . . . . . . . . . . . . . . . . . . . 1222
SEPTEMBER 2014
Bassett Healthcare. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1023
•
www.bhg-inc.com
www.bionixusa.com
BOSTON, MA
www.darcointernational.com
Elsevier Medical Books. . . . . . . . . . . . . . . . . . . . . . . . . . . . 1019
Auxilium Pharmaceuticals, Inc.. . . . . . . . . . . . . . . . . . . . 1815
www.bassett.org
BICOM, Inc. - Diaton . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1134
www.TonometerDiaton.com
Bionix Medical Technologies. . . . . . . . . . . . . . . . . . . . . . 2127
Boehringer Ingelheim Pharmaceuticals, Inc.. . . . . . . 1129
http://us.boehringer-ingelheim.com
Boston Heart Diagnostics. . . . . . . . . . . . . . . . . . . . . . . . . 1932
www.bostonheartdiagnostics.com
www.dannon.com
American College of Physicians. . . . . . . . . . . . . . . . . . . 1412
American Express Open . . . . . . . . . . . . . . . . . . . . . . . . . . 1809
American Latex Allergy Association (ALAA). . . . . . . . 1015
www.astrazeneca-us.com
28
www.cryosurgeryinc.com
Calmoseptine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1731
www.calmoseptineointment.com
CEKeeper. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1732
Cell Science Systems/ALCAT. . . . . . . . . . . . . . . . . . . . . . 2008
www.alcat.com
Concordia Healthcare USA, Inc.. . . . . . . . . . . . . . . . . . . 1331
www.concordiarx.com
Crown Healthcare Apparel Service. . . . . . . . . . . . . . . . 1934
CryoProbe. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1010
www.cryoprobe-na.com
www.elsevier.com
Exalenz Bioscience Ltd. . . . . . . . . . . . . . . . . . . . . . . . . . . . 1832
www.exalenz.com
www.bop.gov
www.frx.com
Genova Diagnostics, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . 1434
www.gdx.net
Gensco Laboratories. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1028
www.genscolabs.com
Gilead Sciences. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1115
www.gilead.com
Grifols USA, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1322
www.grifolsusa.com
Harvard Vanguard Medical Associates. . . . . . . . . . . . . 2315
www.harvardvanguard.org
Health Diagnostic Laboratory. . . . . . . . . . . . . . . . . . . . . 1312
www.myhdl.com
Hemosure Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1323
www.hemosure.com
HireNurses.com. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1628
www.hirenurses.com
HydraFacial MD-Edge Systems LLC. . . . . . . . . . . . . . . . 1008
www.edgeforlife.com
Infinite Therapeutics. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1509
http://infinitetherapeutics.com
Institute for Healthcare Improvement. . . . . . . . . . . . . 2212
www.ihi.org
International Tree Nut Council Nutrition
Research & Education Foundation . . . . . . . . . . . . . . . . 2108
www.nuthealth.org
IPC The Hospitalist Company . . . . . . . . . . . . . . . . . . . . . 1813
www.hospitalist.com
Janssen Pharmaceuticals, Inc.. . . . . . . . . . . . . . . . . . . . . 1108
Kareo. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2131
www.kareo.com
Kowa Pharmaceuticals. . . . . . . . . . . . . . . . . . . . . . . . . . . . 1820
www.kowapharma.com
Exhibitors by Alphabetical Listing
Lab USA, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2132
Rome Foundation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1613
Laclede Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1513
Salix Pharmaceuticals, Inc. . . . . . . . . . . . . . . . . . . . . . . . . 1422
Lippincott Williams & Wilkins. . . . . . . . . . . . . . . . . . . . . . 1025
LocumTenens.com . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1716
Sanofi. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2118
Magine Events. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1908
http://magineevents.com/index.php
Maico Diagnostics. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1031
www.maico-diagnostics.com
Massachusetts Department of Public Health. . . . . . 1534
Merck . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1618
www.merck.com
www.aventis.com
Scarf King . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1608
Shire . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1532
Singulex Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1712
www.singulex.com
Southcoast Health. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2115
www.southcoast.org
Steward Health Care System. . . . . . . . . . . . . . . . . . . . . . 1329
www.steward.org
Micro Direct, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2116
Summit Doppler/Wallach Surgical Devices. . . . . . . . 1512
Millennium Laboratories. . . . . . . . . . . . . . . . . . . . . . . . . . 1909
Sunovion Pharmaceuticals. . . . . . . . . . . . . . . . . . . . . . . . 1429
Minute Clinic. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1831
SureFit. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1431
Mission Pharmacal Co.. . . . . . . . . . . . . . . . . . . . . . . . . . . . 1122
Take Shape for Life. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1518
Takeda Pharmaceuticals U.S.A., Inc.. . . . . . . . . . . . . . . . 1625
www.mdspiro.com
http://millenniumlabs.com
www.minuteclinic.com
www.missionpharmacal.com
Monthly Prescribing Reference. . . . . . . . . . . . . . . . . . . . 1022
Mylan, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1729
www.mylan.com
www.summitdoppler.com
www.sepracor.com
www.surefitlab.com
www.tpna.com
Takeda Pharmaceuticals U.S.A., Inc.. . . . . . . . . . . . . . . . 2121
www.tpna.com
NeilMed Pharmaceuticals, Inc. . . . . . . . . . . . . . . . . . . . . 1515
Tec Laboratories, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1519
New England Journal of Medicine . . . . . . . . . . . . . . . . 1419
TeleEMG. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1032
New York Times. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1812
Novo Nordisk Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1822
The Beef Checkoff. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2112
www.neilmed.com
www.nejm.org
www.novonordisk-us.com
Nurse Practitioners OnCall. . . . . . . . . . . . . . . . . . . . . . . . 1634
www.schwartzmedicalgroup.net
Nutramax Laboratories, Inc.. . . . . . . . . . . . . . . . . . . . . . . 1012
www.nutramaxlabs.com
OAPI-Medical Device Division. . . . . . . . . . . . . . . . . . . . . 1615
http://www.otsuka-us.com
Omron Healthcare. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1016
www.teclabsinc.com
www.nebpi.org
The Gideons International. . . . . . . . . . . . . . . . . . . . . . . . 1610
www.gideons.org
Ultimate Creations. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1709
www.infinitealoe.com
Upsher-Smith Laboratories, Inc.. . . . . . . . . . . . . . . . . . . 1014
www.upsher-smith.com
Verathon. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2318
www.verathon.com
Otto Trading, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1910
Pfizer Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1929
Vita-Mix Corp. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1808
Pri-Med. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pri-Med InLight. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pri-Med Knowledge Zone. . . . . . . . . . . . . . . . . . . . . . . . .
Pri-Med Recharge Lounge. . . . . . . . . . . . . . . . . . . . . . . .
Renua Medical. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Wexford Health Sources . . . . . . . . . . . . . . . . . . . . . . . . . . 1234
www.irestmassager.com
www.pfizer.com
www.renuamedical.com
1529
1315
1912
1522
2308
29
www.teleemg.com
ViroPharma Incorporated. . . . . . . . . . . . . . . . . . . . . . . . . 2316
Vital Nutrients. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2130
http://omronhealthcare.com
www.magicmassagetherapy.com
Sanofi Pasteur Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1915
SEPTEMBER 2014
Magic Massage Therapy. . . . . . . . . . . . . . . . . . . . . . . . . . 1708
www.sanofi-aventis.com
•
http://LocumTenens.com
www.salix.com
BOSTON, MA
www.laclede.com
www.theromefoundation.org
www.vitalnutrients.net
www.vitamix.com
www.wexfordhealth.com
WynnPharm Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1018
www.wynnpharm.com
Xenna Corp.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1834
www.xenna.com
www.labusainc.net
Exhibitors by Product Category
Academia, Associations or Non-profit
Organizations
Exalenz Bioscience Ltd. . . . . . . . . . . . . . . . . . . 1832
Alkermes Inc. . . . . . . . . . . . . . . . . . . . . . . . 1632
Grifols USA, Inc. . . . . . . . . . . . . . . . . . . . . . . 1322
Monthly Prescribing Reference . . . . . . . . . . . . . 1022
Health Diagnostic Laboratory . . . . . . . . . . . . . . 1312
Alzheimer’s Association . . . . . . . . . . . . . . . . . 1009
Hemosure Inc. . . . . . . . . . . . . . . . . . . . . . . . 1323
American College of Physicians . . . . . . . . . . . . . 1412
Lab USA, Inc. . . . . . . . . . . . . . . . . . . . . . . . . 2132
American Latex Allergy Association (ALAA) . . . . . . 1015
American Occupational Therapy Association . . . . . 2113
Institute for Healthcare Improvement . . . . . . . . . 2212
Rome Foundation . . . . . . . . . . . . . . . . . . . . . 1613
Career, Recruitment & Clinician Network
Docnet . . . . . . . . . . . . . . . . . . . . . . . . . . . 1024
Doximity . . . . . . . . . . . . . . . . . . . . . . . . . . 1418
HireNurses.com . . . . . . . . . . . . . . . . . . . . . . 1628
LocumTenens.com . . . . . . . . . . . . . . . . . . . . 1716
Consumer Products & Services
Education
Pri-Med . . . . . . . . . . . . . . . . . . . . . . . . . . . 1529
Pri-Med Knowledge Zone . . . . . . . . . . . . . . . . 1912
Financial Services
American Express Open . . . . . . . . . . . . . . . . . 1809
Bankers Healthcare Group, Inc. . . . . . . . . . . . . . 1222
Government
Federal Bureau of Prisons . . . . . . . . . . . . . . . . 2215
A Fashion Hayvin, Inc. . . . . . . . . . . . . . . . . . . 1508
Government/Healthcare Network or
Provider
Infinite Therapeutics . . . . . . . . . . . . . . . . . . . 1509
Massachusetts Department of Public Health . . . . . 1534
Magic Massage Therapy . . . . . . . . . . . . . . . . . 1708
Otto Trading, Inc. . . . . . . . . . . . . . . . . . . . . . 1910
Scarf King . . . . . . . . . . . . . . . . . . . . . . . . . 1608
30
Genova Diagnostics, Inc. . . . . . . . . . . . . . . . . . 1434
The Gideons International . . . . . . . . . . . . . . . . 1610
Ultimate Creations . . . . . . . . . . . . . . . . . . . . 1709
Vita-Mix Corp. . . . . . . . . . . . . . . . . . . . . . . . 1808
Bassett Healthcare . . . . . . . . . . . . . . . . . . . . 1023
Harvard Vanguard Medical Associates . . . . . . . . . 2315
IPC The Hospitalist Company . . . . . . . . . . . . . . 1813
Nurse Practitioners OnCall . . . . . . . . . . . . . . . . 1634
Southcoast Health . . . . . . . . . . . . . . . . . . . . 2115
Calmoseptine . . . . . . . . . . . . . . . . . . . . . . . 1731
Argyll Diagnostics . . . . . . . . . . . . . . . . . . . . . 1112
CryoProbe . . . . . . . . . . . . . . . . . . . . . . . . . 1010
Millennium Laboratories . . . . . . . . . . . . . . . . . 1909
CryoSurgery, Inc. . . . . . . . . . . . . . . . . . . . . . 1030
OAPI-Medical Device Division . . . . . . . . . . . . . . 1615
Diva International Inc. . . . . . . . . . . . . . . . . . . 1715
Singulex Inc. . . . . . . . . . . . . . . . . . . . . . . . . 1712
HydraFacial MD-Edge Systems LLC . . . . . . . . . . . 1008
Aegis Sciences Corporation . . . . . . . . . . . . . . . 1612
Maico Diagnostics . . . . . . . . . . . . . . . . . . . . 1031
AspirinWorks by Corgenix . . . . . . . . . . . . . . . . 1021
Micro Direct, Inc. . . . . . . . . . . . . . . . . . . . . . 2116
Boston Heart Diagnostics . . . . . . . . . . . . . . . . 1932
Omron Healthcare . . . . . . . . . . . . . . . . . . . . 1016
Cell Science Systems/ALCAT . . . . . . . . . . . . . . .2008
Summit Doppler/Wallach Surgical Devices . . . . . . 1512
BOSTON, MA
SEPTEMBER 2014
Steward Health Care System . . . . . . . . . . . . . . . 1329
•
Dermatology
Healthcare Network or Provider
Diagnostics, Laboratories & Testing
Medical Device
BICOM, Inc. - Diaton . . . . . . . . . . . . . . . . . . . .1134
Verathon . . . . . . . . . . . . . . . . . . . . . . . . . . 2318
Exhibitors by Product Category
Gensco Laboratories . . . . . . . . . . . . . . . . . . . 1028
Bionix Medical Technologies . . . . . . . . . . . . . . 2127
Gilead Sciences . . . . . . . . . . . . . . . . . . . . . . 1115
Crown Healthcare Apparel Service . . . . . . . . . . . 1934
Novo Nordisk Inc. . . . . . . . . . . . . . . . . . . . . . 1822
Darco International . . . . . . . . . . . . . . . . . . . . 2213
Pfizer Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . 1929
Takeda Pharmaceuticals U.S.A., Inc. . . . . . . . . . . . 2121
Dannon Company . . . . . . . . . . . . . . . . . . . . 2109
Janssen Pharmaceuticals, Inc. . . . . . . . . . . . . . . 1108
International Tree Nut Council Nutrition
Research & Education Foundation . . . . . . . . . . . 2108
Kowa Pharmaceuticals . . . . . . . . . . . . . . . . . . 1820
Nutramax Laboratories, Inc. . . . . . . . . . . . . . . . 1012
Mission Pharmacal Co. . . . . . . . . . . . . . . . . . . 1122
Renua Medical . . . . . . . . . . . . . . . . . . . . . . .2308
Mylan, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . 1729
SureFit . . . . . . . . . . . . . . . . . . . . . . . . . . . 1431
Sanofi . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2118
Take Shape for Life . . . . . . . . . . . . . . . . . . . . 1518
Sanofi Pasteur Inc. . . . . . . . . . . . . . . . . . . . . 1915
The Beef Checkoff . . . . . . . . . . . . . . . . . . . . 2112
Shire . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1532
Vital Nutrients . . . . . . . . . . . . . . . . . . . . . . . 2130
Sunovion Pharmaceuticals . . . . . . . . . . . . . . . . 1429
WynnPharm Inc. . . . . . . . . . . . . . . . . . . . . . . 1018
ViroPharma Incorporated . . . . . . . . . . . . . . . . 2316
OTC Medicine and Treatment
Laclede Inc. . . . . . . . . . . . . . . . . . . . . . . . . 1513
NeilMed Pharmaceuticals, Inc. . . . . . . . . . . . . . .1515
Tec Laboratories, Inc. . . . . . . . . . . . . . . . . . . . 1519
Xenna Corp. . . . . . . . . . . . . . . . . . . . . . . . . 1834
Pharmaceutical
Merck . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1618
Pharmacy
Minute Clinic . . . . . . . . . . . . . . . . . . . . . . . . 1831
Practice Management
Amazing Charts . . . . . . . . . . . . . . . . . . . . . . 1415
Kareo . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2131
Pri-Med InLight . . . . . . . . . . . . . . . . . . . . . . 1315
AbbVie . . . . . . . . . . . . . . . . . . . . . . . . . . . 2125
Wexford Health Sources . . . . . . . . . . . . . . . . . 1234
Astellas Pharma U.S., Inc. . . . . . . . . . . . . . . . . . 1829
AstraZeneca . . . . . . . . . . . . . . . . . . . . . . . . 1218
Auxilium Pharmaceuticals, Inc. . . . . . . . . . . . . . 1713
Auxilium Pharmaceuticals, Inc. . . . . . . . . . . . . . 1815
Boehringer Ingelheim
Pharmaceuticals, Inc. . . . . . . . . . . . . . . . . . . . 1129
Concordia Healthcare USA, Inc. . . . . . . . . . . . . . 1331
31
AndaMEDS . . . . . . . . . . . . . . . . . . . . . . . . . 1223
AbbVie . . . . . . . . . . . . . . . . . . . . . . . . . . . 1925
Akrimax Pharmaceuticals LLC . . . . . . . . . . . . . . 1027
Upsher-Smith Laboratories, Inc. . . . . . . . . . . . . . 1014
Publishing
Elsevier Medical Books . . . . . . . . . . . . . . . . . . 1019
Lippincott Williams & Wilkins . . . . . . . . . . . . . . 1025
Magine Events . . . . . . . . . . . . . . . . . . . . . . . 1908
New England Journal of Medicine . . . . . . . . . . . 1419
New York Times . . . . . . . . . . . . . . . . . . . . . . 1812
Technology
Eisai, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . 1425
CEKeeper . . . . . . . . . . . . . . . . . . . . . . . . . . 1732
Forest Pharmaceuticals, Inc. . . . . . . . . . . . . . . . 1125
TeleEMG . . . . . . . . . . . . . . . . . . . . . . . . . . 1032
SEPTEMBER 2014
Nutrition & Wellness
Takeda Pharmaceuticals U.S.A., Inc. . . . . . . . . . . . 1625
•
Pri-Med Recharge Lounge . . . . . . . . . . . . . . . . 1522
Salix Pharmaceuticals, Inc. . . . . . . . . . . . . . . . . 1422
BOSTON, MA
Miscellaneous
Medical Supplies & Equipment
BICOM,
IncDiaton
1134
Shire
Alkermes
Xenna
Corp
Crown
Healthcare
Apparel
Service
1932 1934
Boston
Heart
Diagnostics
2132
Lab USA
Kareo
1732 1832 1834
Nurse
Exalenz
Practitioners CEKeeper Bioscience
OnCall
Ltd
2131
1628 1632 1634
Massachusetts
Department of HireNurses.com
Public Health
1831
1929
AbbVie
1925
1820
Sanofi
Pasteur
Inc
1915
Pri-Med
Knowledge
Zone
2130
Bionix
Medical
Tech
AbbVie
2127
2125
2313
2314
2315
Harvard
Vanguard
Medical
2316
ViroPharma
2318
Verathon
2319
2122
2123
2124
TO GENERAL
SESSION
Takeda
Pharmaceuticals
U.S.A., Inc
2215
Prisons
2216
2218
2219
2121
Sanofi
2118
Micro
Direct
2116
2115
Southcoast Federal
Bureau of
Health
Darco
Int'l
2312
2213
2310
2113
2210
2309
American
Occupational
Therapy
2209
2308
2212
2109
2208
Institute for
Healthcare
Improvement
2010
Int'l Tree Nut
Council Nutrition
Research &
Education
Foundation
2112
1910
2009
2108
The Beef
Checkoff
1909
2008
Cell Science
Systems/
ALCAT
The
Dannon
Co
Magine
Events
Otto
Trading
1908
1912
Vital
Nutrients
Minute
Clinic
1829
Pfizer Inc.
1731
Mylan,
Inc
Calmoseptine
Pri-Med
1729
Takeda
Pharmaceuticals
U.S.A., Inc
1625
1812
1610
Kowa
Pharmaceuticals
Novo
Nordisk
1822
Auxilium
Pharmaceuticals
1813
IPC The
Hospitalist
1815
1713
Auxilium
Pharmaceuticals
1715
Diva Int'l
Inc
1716
LocumTenens.com
Merck
1618
1522
Neilmed
Pharmaceuticals
1613
Rome
Foundation
1615
OAPIMedical
Device
Division
Laclede
Inc
1515
1513
1712
Singulex New York
Times
Inc
American
Expr
Open
1612
Aegis
Sciences
Ultimate
Creations
1809
1512
Summit Doppler/
Wallach Surgical
Devices
Astellas
Pharma
U.S.,
Inc
1431
1430
1429
Sunovion
Pharmaceuticals
1425
Salix
Pharmaceuticals
1422
1519
Pri-Med
Recharge
Lounge
Eisai, Inc.
1529
SureFit
1234 1331 1434 1532 1534
Wexford Concordia Genova
Health Healthcare Diagnostics
Sources USA, Inc
Steward
Health
Care
Systems
1329
1323
Hemosure
Grifols
USA
1322
1419
New
Televox
England Software
Journal
1520
of
Medicine Tec Labs
Inc
1518
Take
Shape
for Life
1418
Doximity
1415
Pri-Med Amazing
InLight Charts
1315
1412
Health
American
Diagnostic College of
Laboratory Physicians
1312
1709
The
Gideons
1609
Magic
Vita Mix
Massage
Corp
Therapy
I.C. E.,
Inc
1509
Scarf
King
1808
1608
1708
1508
A Fashion
Hayvin
SEPTEMBER 2014
1032
TeleEMG
Boehringer
Ingelheim
Pharmaceuticals
1129
Forest
Pharmaceuticals
1125
1223
1222
Bankers
Healthcare
Grp Inc
Mission AndaMEDS
Pharmacal
Co
1122
AstraZeneca
1218
Gilead
Sciences
1115
Argyll
Diagnostics
1112
Janssen
Pharmaceuticals
1108
•
TO GENERAL
SESSION
1031
Maico
Diagnostics
1030
CryoSurgery
Gensco
Labs
1028
Akrimax
Pharmaceuticals
LLC
1027
1025
Lippincott
Williams &
Wilkins
1024
Cegedim
1023
Bassett
Healthcare
1022
Monthly
Prescribing
Reference
1021
Aspirin
Works By
Corgenix
1019
Elsevier
Medical
Books
1018
WynnPharm
1016
Omron
Healthcare
1015
American Latex
Allergy Assoc
(ALAA)
1014
UpsherSmith
Labs Inc
Nutramax
Labs Inc
1012
1010
CryoProbe
1009
Alzheimers
1008
HydraFacial
MD-Edge
Sys LLC
CAFE AREA
BOSTON, MA
RESTROOM
Exhibit Hall
PRESENTATION
THEATER #1
PRESENTATION
THEATER #2
PRESENTATION
THEATER #3
32
125
112
104
Fre
Staging
Area
Staging
Area
Staging
Area
Service Corridor
Strg.
Corridor
Staging
Area
Staging
Area
AV/TC
Room
Staging
Area
Staging
Area
BOSTON, MA
Prefunction
Service Corridor
AV/TC
Room
•
Balcony
Pick-up/Drop-off
Registration Lobby
East
Balcony
Office
Seating
Office
Strg.
Staging
Area
HALL B
Ground Level
GENERAL
SESSION
SEPTEMBER 2014
RESTROOMS
Seating
Seating
Registration Lobby
West
0
5
10
20
SCALE IN FEET
30
40
Prefunction
AV/TC
Room
Food Court
G101
Bar
Lobby
Strg.
Security
Office
155
Office
Seating
Balcony
To
Exhibits
Pick-up/Drop-off
Registration Lobby East
Balcony
To
General
Session
J.C.
RESTROOMS
Seating
Seating
Pantry
RESTROOMS
Service Corridor
AV/TC
Room
Pantry
AC User
Conference
104AB
Staging
Area
Service Corridor
Staging
Area
Staging
Area
Show
Management
Office
151A
Staging
Area
Staging
Area
Strg.
Strg.
Staging
Area
Staging
Area
Line of Floor Above
Office
C117
Office
C118
Office
C119
Bag Stg
Strg.
Office
Bag Stg
Office
IDF
FedEx/
Kinko's
J.C.
Concourse
TO
GENERAL
SESSION
Ticket Booths
Registration
TO
GENERAL
SESSION
Concourse
EXTERIO R WALKWAY
Info.
*This floor plan is subject to fire marshal approval.
Prefunction
Presentation
Theater #4
153ABC
AV/TC
Room
EXHIBITS
Staging
Area
AC
Exhibits
& F&B
104C
Staging
Area
Office
Registration Lobby
West
Pedestrian Bridge
SKYBRIDGE
RESTROOMS
BOSTON CONVENTION & EXHIBITION CENTER - LEVEL 1
BOSTON, MASSACHUSETTS
Floor Above
Floor Above
THURSDAY, SEPTEMBER 11 - SUNDAY, SEPTEMBER 14, 2014
Pedestrian Bridge
Pedestrian Bridge
Pedestrian Bridge
Bridge Above
Bridge Above
Glass wall
Glass wall
Level 1
Balcony Above
PRI-MED EAST
EXIT
EXIT
STAIRS UP & DOWN
HANDICAP
T STOP
CS
CS
07/18/14
07/23/14
07/25/14
00/00/00
2
3
4
5
289212
COPYRIGHT 2007, FREEMAN CO.
ALL RIGHTS RESERVED.
EVERY EFFORT HAS BEEN MADE TO
ENSURE THE ACCURACY OF ALL
INFORMATION CONTAINED ON THIS
FLOORPLAN. HOWEVER NO WARRANTIES,
EITHER EXPRESSED OR IMPLIED ARE
MADE WITH RESPECT TO THIS FLOORPLAN.
IF THE LOCATION OF BUILDING COLUMNS,
UTILITIES OR OTHER ARCHITECTURAL
COMPONENTS OF THE FACILITY IS
A CONSIDERATION IN THE CONSTRUCTION
OR USAGE OF AN EXHIBIT, IT IS THE SOLE
RESPONSIBILITY OF THE EXHIBITOR TO
PHYSICALLY INSPECT THE FACILITY TO
VERIFY ALL DIMENSIONS AND LOCATIONS.
DISCLAIMER
Freeman Boston
Jenny Palm
Acct. Loc.:
Acct. Exec.:
Boston Convention &
Exhibition Center
September 12 - 14, 2014
Pri-Med East
2014
PMEast14 Lvl 1 FP ONSITE GUIDE ONLY
Job Number:
Facility:
Show Dates:
Show Name:
File Name:
NORTH EAST REGIONAL
DESIGN CENTER
BOSTON
CS
07/17/14
1
00
CS
DATE
NUMBER
INITIAL
06/19/14 CS
BUS STOP
FREIGHT ELEVATOR
LOADING DOCK
FREIGHT FREE AISLE
SECURITY OFFICE
MEETING ROOM
WATER CONNECTION
WATER FOUNTAIN
FIRE EXTINGUISHER
FIRE HOSE CABINET
FIRE STROBE
COAT ROOM
PUBLIC TELEPHONES
INFORMATION
FIRST AID
COFFEE
FOOD
DOWN ESCALATORS
UP ESCALATORS
UP/DOWN ESCALATORS
STAIRS UP
STAIRS DOWN
REVISIONS
Drawing Started on:
FH
HANDICAP WOMEN'S ROOM
HANDICAP MEN'S ROOM
UNISEX RESTROOM
MEN'S ROOM
WOMEN'S ROOM
EMERGENCY EXIT
EXIT
EE
EXIT
H.C. ELEVATOR
ELEVATOR
SYMBOLS LEGEND
33
F S PAN T RY 131
F S PAN T R Y K131
F S PAN T R Y M028
BOSTON, MA
•
RESTROOMS
RESTROOMS
Lobby
East
Lobby
West
RESTROOMS
RESTROOMS
F S394
PRI-MED EAST
Service Corridor
F S699.2
SYMPOSIA
210
F S220.2
F S308
RESTROOMS
Meeting Room
208
RESTROOMS
Lobby
East
Lobby
West
RESTROOMS
RESTROOMS
Service Corridor
F S699.1
F S699.1
USC Ultrasound
Demo Room
205A
F S220.1
F S PAN T RY D131
BOSTON CONVENTION & EXHIBITION CENTER - LEVEL 2 BOSTON,
MASSACHUSETTS
F S760
F S707
F S710.2
F S710.1
F S408.4
F S408.3
F S408.2
F S408.1
F S407
New
Mother's
Room
203
Kitchen
Lobby
Below
Lobby
Below
Level 2
Bridge
FRIDAY, SEPTEMBER 12 - SUNDAY, SEPTEMBER 14, 2014
SEPTEMBER 2014
34
ybridge to
Westin
Show Dates:
Show Name:
DISCLAIMER
Free
Je
Boston
Exhi
Septem
Pri
PMEast14 Lvl
COPYRIGHT 2007, FREE
ALL RIGHTS RESER
EVERY EFFORT HAS BEE
ENSURE THE ACCURA
INFORMATION CONTAIN
FLOORPLAN. HOWEVER NO
EITHER EXPRESSED OR I
MADE WITH RESPECT TO THI
IF THE LOCATION OF BUILDI
UTILITIES OR OTHER ARC
COMPONENTS OF THE F
A CONSIDERATION IN THE C
OR USAGE OF AN EXHIBIT, I
RESPONSIBILITY OF THE E
PHYSICALLY INSPECT THE
VERIFY ALL DIMENSIONS AN
Acct. Loc.:
Acct. Exec.:
Job Number:
Facility:
BOSTO
00/00/00
07/25/14
07/23/14
NORTH EAST RE
DESIGN CENT
File Name:
5
4
3
07/18/14
1
2
DATE
07/17/14
NUMBER
REVISION
Drawing Started on:
BOSTON, MA
•
SEPTEMBER 2014
Service Corridor
Storage
Service Corridor
Elevator
Lobby
Elevator
Lobby
Green Room
Ballroom
Storage
Grand Ballroom
And Session
Room #2
Ballroom
Storage
Level 3
BOSTON CONVENTION & EXHIBITION CENTER - LEVEL 3
BOSTON, MASSACHUSETTS
DATE
BOSTON
00/00/00
00/00/00
00/00/00
00/00/00
07/17/14
289
DISCLAIMER
Freeman
Jenny
COPYRIGHT 2007, FREEMAN C
ALL RIGHTS RESERVED.
EVERY EFFORT HAS BEEN MA
ENSURE THE ACCURACY OF
INFORMATION CONTAINED ON
FLOORPLAN. HOWEVER NO WAR
EITHER EXPRESSED OR IMPLIE
MADE WITH RESPECT TO THIS FL
IF THE LOCATION OF BUILDING C
UTILITIES OR OTHER ARCHITEC
COMPONENTS OF THE FACILI
A CONSIDERATION IN THE CONST
OR USAGE OF AN EXHIBIT, IT IS T
RESPONSIBILITY OF THE EXHIBI
PHYSICALLY INSPECT THE FACI
VERIFY ALL DIMENSIONS AND LO
Acct. Loc.:
Acct. Exec.:
Job Number:
Boston Con
Exhibitio
September 1
Show Dates:
Facility:
Pri-Me
20
Show Name:
PMEast14 Lvl 3 FP M
NORTH EAST REGION
DESIGN CENTER
File Name:
5
4
3
2
1
NUMBER
06/
REVISIONS
Drawing Started on:
35
You are invited to an Industry Product Theater (Non-CME) Presentation
at the Pri-Med East 2014 Annual Conference
Discussion of a
Treatment Option
for Major Depressive Disorder
11:50 am - 12:35 pm
Theater 3
Boston, Massachusetts
GUEST SPEAKER
Gregory W. Mattingly, MD
Associate Clinical Professor
Department of Psychiatry
Washington University School of Medicine
St. Louis, Missouri
President
Midwest Research Group
St. Charles, Missouri
This is an industry sponsored presentation;
no CME credits will be given for attending.
Sponsored by Takeda Pharmaceuticals U.S.A., Inc. & Lundbeck
Takeda Pharmaceuticals U.S.A., Inc. & Lundbeck
94341
9/2014

PRI-MED EAST

Transcription

Similar documents

Dear Red Sox Nation

How to nap - Boston.com

About Clerys: Side Room Function Space

The name is now

Fact Sheet

collaborations - Women Of The World

detailed in this brochure

1989 Boston Whaler Outrage 18

Online Casino Games Without Downloading

Rally Flyer - The Massachusetts Teachers Association